Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase M10.003: matrix metallopeptidase-2

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Inhibitors Pharma

(Topics flags: S Structure, A Assay, T Target, P Specificity, K Knockout, E Expression, V Review, M Mutation, I Inhibitor, R Splicing, L Localization, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

    2026
  1. Luo,Q., Zheng,C., Huang,Y., Liang,L., Gong,Y., Zhang,J., Tang,Q., Zhang,K. and Liao,X.
    Polydopamine-stabilized CsPbBr(3) enables toxicity-reduced ECL detection of MMP-2 via CRISPR/Cas12a trans-cleavage
    Biosens Bioelectron (2026) 293, 118193-118193. PubMed  Europe PubMed DOI
    2. 2025
  2. Conde-Tella,S.O., Gerlach,R.F. and Tanus-Santos,J.E.
    Using Zymography to Assess Circulating Matrix Metalloproteinase (MMP)-2 and MMP-9 in Clinical Samples
    Methods Mol Biol (2025) 2918, 177-186. PubMed  Europe PubMed DOI  L
  3. George,J.
    Zymography: A Simple and Powerful Tool for the Assessment of MMP-2 and MMP-9 in Pathological Conditions
    Methods Mol Biol (2025) 2918, 187-199. PubMed  Europe PubMed DOI  L
  4. Lempicki,M.D., Garrigues,R.J., Hondros,A.D., Zeczycki,T.N., Garcia,B.L., Cavanagh,J., Harris,T.E. and Meher,A.K.
    Matrix metalloproteinase-2 as a novel regulator of glucose utilization by adipocytes
    Sci Rep (2025) 15, 24277-24277. PubMed  Europe PubMed DOI  PMC  EPMC
  5. Lin,X., Chen,Y., Zhong,B. and Yu,H.
    Cathepsin K and glycosaminoglycans differentially regulate matrix metalloproteinase activity in dentin under various pH conditions
    Int J Biol Macromol (2025) 327, 147486-147486. PubMed  Europe PubMed DOI  L
  6. O'Neill,K.L., Zigmond,J.W. and Bergan,R.
    HSP90alpha and KLK6 Co-Regulate Stress-Induced Prostate Cancer Cell Motility
    bioRxiv (2025) PubMed  Europe PubMed DOI  PMC  EPMC  K  L
  7. Sarker,H., Panigrahi,R., Lopez-Campistrous,A., McMullen,T., Reyes,K., Anderson,E., Krishnan,V., Hernandez-Anzaldo,S., Zheng,X.L., Glover,J.N.M., Hardy,E. and Fernandez-Patron,C.
    Apolipoprotein-A1 transports and regulates MMP2 in the blood
    Nat Commun (2025) 16, 3752-3752. PubMed  Europe PubMed DOI  PMC  EPMC
  8. Sun,N., Wang,S., Liu,J., Zhang,P., Chang,Y., Li,H., Zhao,K., Liu,Y., Huang,M., Hu,Y., Lin,Z., Lu,Y., Jiang,G., Chen,W., Huang,C. and Jin,H.
    XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1
    Cell Death Dis (2025) 16, 205-205. PubMed  Europe PubMed DOI  PMC  EPMC
  9. Takatsuka,R., Terashima,M., Ishimura,A., Suzuki,T. and Takino,T.
    Iron regulates MT1-MMP-mediated proMMP-2 activation and cancer cell invasion
    Biochem Biophys Res Commun (2025) 742, 151124-151124. PubMed  Europe PubMed DOI
  10. Veilleux,C., Roy,M.E. and Annabi,B.
    Assessing MMP-2/9 Proteolytic Activity and Activation Status by Zymography in Preclinical and Clinical Tissue Samples
    Methods Mol Biol (2025) 2918, 165-176. PubMed  Europe PubMed DOI  L
  11. Zhu,Q., Sun,X., Du,Y., Zhang,X., Ren,X., Ma,H., Wu,D., Ju,H. and Wei,Q.
    Detection of Matrix Metalloproteinase 2 by a Polypeptide Cleavable Split-Type Sensor Based on Atomically Precise Bimetallic Nanocluster Au(3)Ag(5)(MSA)(3)
    Anal Chem (2025) 97, 14574-14583. PubMed  Europe PubMed DOI  A
    12. 2024
  12. Alekhmimi,N., Ramadan,Q., Cialla-May,D., Popp,J., Al-Kattan,K., Alhoshani,A. and Zourob,M.
    In Vivo Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Imaging of MMP-2 in ALI/ARDS in LPS-Treated Mice
    ACS Omega (2024) 9, 3609-3615. PubMed  Europe PubMed DOI  PMC  EPMC
  13. Blascke de Mello,M.M., Neves,V.G.O., Parente,J.M., Pernomian,L., de Oliveira,I.S., Pedersoli,C.A., Awata,W.M.C., Tirapelli,C.R., Arantes,E.C., Tostes,R.C.A., Schulz,R. and Castro,M.M.
    Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension
    Eur J Pharmacol (2024) 983, 176981-176981. PubMed  Europe PubMed DOI  L
  14. Capelli,L., Pedrini,F., Di Pede,A.C., Chamorro-Garcia,A., Bagheri,N., Fortunati,S., Giannetto,M., Mattarozzi,M., Corradini,R., Porchetta,A. and Bertucci,A.
    Synthetic Protein-to-DNA Input Exchange for Protease Activity Detection Using CRISPR-Cas12a
    Anal Chem (2024) PubMed  Europe PubMed DOI
  15. Cavalcante,G.L., Bonifacio,L.P., Sanches-Lopes,J.M., Puga,F.G., de Carvalho,F.S., Bellissimo-Rodrigues,F. and Tanus-Santos,J.E.
    Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target
    Basic Clin Pharmacol Toxicol (2024) 134, 727-736. PubMed  Europe PubMed DOI  L
  16. Chen,Y., Zhu,D., Zhong,H., Gan,Z., Zong,S., Wang,Z., Cui,Y. and Wang,Y.
    Ultrasensitive Detection of Matrix Metalloproteinase 2 Activity Using a Ratiometric Surface-Enhanced Raman Scattering Nanosensor with a Core-Satellite Structure
    ACS Appl Mater Interfaces (2024) 16, 4160-4168. PubMed  Europe PubMed DOI
  17. Cioates Negut,C., Ilie-Mihai,R.M. and Stefan-van Staden,R.I.
    Determination of Matrix Metalloproteinase 2 in Biological Samples Using a 3D Stochastic Microsensor Based on Graphene Oxide/AuNanoparticles/(Z)-N-(pyridin-4-yl-methyl) Octadec-9-enamide
    Int J Mol Sci (2024) 25 PubMed  Europe PubMed DOI  PMC  EPMC
  18. Gong,Y., Zhang,J., Xi,Y., Jian,D., Zhuo,C., Tang,Q., Zhang,K. and Liao,X.
    Highly sensitive detection of MMP-2 using an electrochemiluminescent biosensor enhanced by ladder-branch hybridization chain reaction
    Mikrochim Acta (2024) 191, 742-742. PubMed  Europe PubMed DOI
  19. Guo,J., Hu,M., Yang,M., Cao,H., Li,H., Zhu,J., Li,S. and Zhang,J.
    Inhibition mechanism of theaflavins on matrix metalloproteinase-2: inhibition kinetics, multispectral analysis, molecular docking and molecular dynamics simulation
    Food Funct (2024) PubMed  Europe PubMed DOI
  20. Kamarajan,P., Timm,J.C., Goetting-Minesky,M.P., Malone,E.T., Ganther,S., Radaic,A., Tafolla,C., Fenno,J.C. and Kapila,Y.L.
    Purification of Native Dentilisin Complex from Treponema denticola by Preparative Continuous Polyacrylamide Gel Electrophoresis and Functional Analysis by Gelatin Zymography
    Bio Protoc (2024) 14, e4970-e4970. PubMed  Europe PubMed DOI  PMC  EPMC  L
  21. Morokuma,J., Garriz,A., Toribio,D., Pagni,S. and Zoukhri,D.
    Interleukin-1beta activates matrix metalloproteinase-2 to alter lacrimal gland myoepithelial cell structure and function
    Front Ophthalmol (Lausanne) (2024) 4, 1415002-1415002. PubMed  Europe PubMed DOI  PMC  EPMC
  22. Shi,Z., Yan,J., Zhao,M., Li,S., She,T. and Qian,X.
    Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells
    J Control Release (2024) 369, 658-667. PubMed  Europe PubMed DOI
    23. 2023
  23. Baidya,S.K., Banerjee,S., Ghosh,B., Jha,T. and Adhikari,N.
    Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches
    SAR QSAR Environ Res (2023) 34, 805-830. PubMed  Europe PubMed DOI
  24. Bassiouni,W., Valencia,R., Mahmud,Z., Seubert,J.M. and Schulz,R.
    Matrix metalloproteinase-2 proteolyzes mitofusin-2 and impairs mitochondrial function during myocardial ischemia-reperfusion injury
    Basic Res Cardiol (2023) 118, 29-29. PubMed  Europe PubMed DOI  L
  25. Hayun,H., Coban,M., Bhagat,A.K., Ozer,E., Alfonta,L., Caulfield,T.R., Radisky,E.S. and Papo,N.
    Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
    Res Sq (2023) PubMed  Europe PubMed DOI  PMC  EPMC
  26. Hayun,H., Coban,M., Bhagat,A.K., Ozer,E., Alfonta,L., Caulfield,T.R., Radisky,E.S. and Papo,N.
    Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
    Sci Rep (2023) 13, 5186-5186. PubMed  Europe PubMed DOI  PMC  EPMC
  27. Ishaq,T., Loid,P., Ishaq,H.A., Seo,G.H., Makitie,O. and Naz,S.
    Clinical, radiographic and molecular characterization of two unrelated families with multicentric osteolysis, nodulosis, and arthropathy
    BMC Musculoskelet Disord (2023) 24, 735-735. PubMed  Europe PubMed DOI  PMC  EPMC
  28. Kowalczyk,A., Nisiewicz,M.K., Bamburowicz-Klimkowska,M., Kasprzak,A., Ruzycka-Ayoush,M., Koszytkowska-Stawinska,M. and Nowicka,A.M.
    Effective voltammetric tool for simultaneous detection of MMP-1, MMP-2, and MMP-9; important non-small cell lung cancer biomarkers
    Biosens Bioelectron (2023) 229, 115212-115212. PubMed  Europe PubMed DOI
  29. Li,P.H., Liao,C.H., Huang,W.C., Chang,W.S., Wu,H.C., Hsu,S.W., Chen,K.Y., Wang,Z.H., Hsia,T.C., Bau,D.T. and Tsai,C.W.
    Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk
    Anticancer Res (2023) 43, 343-349. PubMed  Europe PubMed DOI
  30. Luo,F.F., Wang,J., Zhang,Z.F., Lin,S.T., Huang,T.J., Liu,B.Q., Fan,M.L., Peng,L.X., Zheng,S.T., Yang,C.F. and Huang,B.J.
    SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2
    Front Biosci (Landmark Ed) (2023) 28, 212-212. PubMed  Europe PubMed DOI
  31. Reddy,R.A., Sai Varshini,M. and Kumar,R.S.
    Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression
    Recent Pat Anticancer Drug Discov (2023) 20, 26-44. PubMed  Europe PubMed DOI  V
  32. Ribeiro Vitorino,T., Ferraz do Prado,A., Bruno de Assis Cau,S. and Rizzi,E.
    MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension
    Biochem Pharmacol (2023) 215, 115684-115684. PubMed  Europe PubMed DOI  V
  33. Samah,N., Ugusman,A., Hamid,A.A., Sulaiman,N. and Aminuddin,A.
    Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease
    Mediators Inflamm (2023) 2023, 9715114-9715114. PubMed  Europe PubMed DOI  PMC  EPMC  V
  34. Sangwan,P., Quasimi,H., Sharma,J.G., Habib,M.A. and Alam,M.I.
    Role of Oxidative Stress and Genetic Polymorphism of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in COPD
    Chronic Obstr Pulm Dis (2023) PubMed  Europe PubMed DOI  V
  35. Takeuchi,T., Nomura,Y., Tamita,T., Nishikawa,R., Kakinuma,H., Kojima,N., Hitaka,K., Tamura,Y., Kamitani,M., Mima,M., Nozoe,A. and Hayashi,M.
    Discovery of TP0597850: A Selective, Chemically Stable, and Slow Tight-Binding Matrix Metalloproteinase-2 Inhibitor with a Phenylbenzamide-Pentapeptide Hybrid Scaffold
    J Med Chem (2023) 66, 822-836. PubMed  Europe PubMed DOI  I
  36. Weekley,B.H. and Rice,J.C.
    The MMP-2 histone H3 N-terminal tail protease is selectively targeted to the transcription start sites of active genes
    Epigenetics Chromatin (2023) 16, 16-16. PubMed  Europe PubMed DOI  PMC  EPMC
  37. Yao,T., Chen,J., Kong,L., Liu,Y., Yuan,R. and Chai,Y.
    Efficient Three-Dimensional DNA Nanomachine Guided by a Robust Tetrahedral DNA Nanoarray Structure for the Rapid and Ultrasensitive Electrochemical Detection of Matrix Metalloproteinase 2
    Anal Chem (2023) 95, 13211-13219. PubMed  Europe PubMed DOI
  38. Zhang,Y.N., Liu,J.J., Zhang,W., Qin,H.Y., Wang,L.T., Chen,Y.Y., Yuan,L., Yang,F., Cao,R.Y. and Wang,X.J.
    Expression, purification and refolding of pro-MMP-2 from inclusion bodies of E. coli
    Protein Expr Purif (2023) 208-209, 106278-106278. PubMed  Europe PubMed DOI  L
  39. Zhu,X., Song,Y., Wang,X., Zhou,Y., Chai,Y. and Yuan,R.
    Copper nanoclusters electrochemiluminescence with tunable near-infrared emission wavelength for ultrasensitive detection of matrix metalloproteinase-2
    Biosens Bioelectron (2023) 238, 115580-115580. PubMed  Europe PubMed DOI
    40. 2022
  40. Maybee,D.V., Ink,N.L. and Ali,M.A.M.
    Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu
    Int J Mol Sci (2022) 23 PubMed  Europe PubMed DOI  PMC  EPMC  V
  41. Morales-Hernandez,F.V., Bautista-Bautista,G., Acuna-Gonzalez,R.J., Vazquez-Cardenas,P., Lopez-Canales,J.S., Lozano-Cuenca,J., Osorio-Caballero,M. and Flores-Herrera,H.
    Differential proMMP-2 and proMMP-9 secretion in human pre-implantation embryos at day 5 of development
    Acta Biochim Pol (2022) 69, 683-689. PubMed  Europe PubMed DOI  L
  42. Sanyal,S., Amin,S.A., Banerjee,P., Gayen,S. and Jha,T.
    A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design
    Bioorg Med Chem (2022) 74, 117044-117044. PubMed  Europe PubMed DOI
    43. 2021
  43. Ali,M.A.M., Garcia-Vilas,J.A., Cromwell,C.R., Hubbard,B.P., Hendzel,M.J. and Schulz,R.
    Matrix metalloproteinase-2 mediates ribosomal RNA transcription by cleaving nucleolar histones
    FEBS J (2021) PubMed  Europe PubMed DOI
  44. Anuar,N.N.M., Zulkafali,N.I.N. and Ugusman,A.
    Modulation of Matrix Metalloproteinases by Plant-Derived Products
    Curr Cancer Drug Targets (2021) 21, 91-106. PubMed  Europe PubMed DOI  V  I
  45. Bassiouni,W., Ali,M.A.M. and Schulz,R.
    Multifunctional intracellular matrix metalloproteinases: implications in disease
    FEBS J (2021) 288, 7162-7182. PubMed  Europe PubMed DOI  V
  46. Bourgi,R., Daood,U., Bijle,M.N., Fawzy,A., Ghaleb,M. and Hardan,L.
    Reinforced Universal Adhesive by Ribose Crosslinker: A Novel Strategy in Adhesive Dentistry
    Polymers (Basel) (2021) 13 PubMed  Europe PubMed DOI  PMC  EPMC
  47. Buttacavoli,M., Di Cara,G., Roz,E., Pucci-Minafra,I., Feo,S. and Cancemi,P.
    Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9
    Int J Mol Sci (2021) 22 PubMed  Europe PubMed DOI  PMC  EPMC  L
  48. Fang,Y., Li,Y., Li,Y., He,R., Zhang,Y., Zhang,X., Liu,Y. and Ju,H.
    In Situ Protease Secretion Visualization and Metastatic Lymph Nodes Imaging via a Cell Membrane-Anchored Upconversion Nanoprobe
    Anal Chem (2021) 93, 7258-7265. PubMed  Europe PubMed DOI
  49. Goossens,J.F., Goossens,L. and Bailly,C.
    Hinokiflavone and Related C-O-C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of Action
    Nat Prod Bioprospect (2021) PubMed  Europe PubMed DOI  PMC  EPMC  V  I
  50. Harwood,S.L., Nielsen,N.S., Diep,K., Jensen,K.T., Nielsen,P.K., Yamamoto,K. and Enghild,J.J.
    Development of selective protease inhibitors via engineering of the bait region of human alpha2-macroglobulin
    J Biol Chem (2021) 297, 100879-100879. PubMed  Europe PubMed DOI  PMC  EPMC
  51. Lenci,E., Angeli,A., Calugi,L., Innocenti,R., Carta,F., Supuran,C.T. and Trabocchi,A.
    Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II
    Eur J Med Chem (2021) 214, 113260-113260. PubMed  Europe PubMed DOI
  52. Li,X., Jin,L. and Tan,Y.
    Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (Review)
    Mol Med Rep (2021) 23 PubMed  Europe PubMed DOI
  53. Liu,C.F., Xia,Y., To,J., Chan,N.Y., Hu,S., Liew,H.T., Balamkundu,S., Zhang,X., Lescar,J., Bhattacharjya,S. and Tam,J.P.
    Ngamma-Hydroxyasparagine: a Multifunctional Unnatural Amino Acid That is a Good P1 Substrate of Asparaginyl Peptide Ligases
    Angew Chem Int Ed Engl (2021) PubMed  Europe PubMed DOI  I
  54. Liu,F., Chen,R., Song,W., Li,L., Lei,C. and Nie,Z.
    Modular Combination of Proteolysis-Responsive Transcription and Spherical Nucleic Acids for Smartphone-Based Colorimetric Detection of Protease Biomarkers
    Anal Chem (2021) 93, 3517-3525. PubMed  Europe PubMed DOI
  55. Nissi,R., Santala,M. and Talvensaari-Mattila,A.
    The serum levels of circulating matrix metalloproteinase MMP-9, MMP-2/TIMP-2 complex and TIMP-1 do not change significantly during normal pregnancy: a pilot study
    BMC Res Notes (2021) 14, 31-31. PubMed  Europe PubMed DOI  PMC  EPMC
  56. Rocchi,D., Blazquez-Barbadillo,C., Agamennone,M., Laghezza,A., Tortorella,P., Vicente-Zurdo,D., Rosales-Conrado,N., Moyano,P., Pino,J.D., Gonzalez,J.F. and Menendez,J.C.
    Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity
    Eur J Med Chem (2021) 210, 113061-113061. PubMed  Europe PubMed DOI  I
  57. Tarki,S.E., Far,I.S., Aminimoghaddam,S., Fooladi,B., Sarhangi,N., Farahani,M.S., Klashami,Z.N., Hamidi,A.K. and Amoli,M.M.
    Investigating the association of matrix metalloproteinase-2 gene variants with endometriosis in an Iranian population
    Eur J Obstet Gynecol Reprod Biol (2021) 258, 353-357. PubMed  Europe PubMed DOI
  58. Tsegaye,S., Mehdi,M., Labisso,W.L. and Melka,D.S.
    Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients
    Breast Cancer (Dove Med Press) (2021) 13, 271-283. PubMed  Europe PubMed DOI  PMC  EPMC  L
  59. Yuan,X., Bian,X., Wei,W., Bao,Q., Liu,P. and Jiang,W.
    miR-34a regulates phenotypic modulation of vascular smooth muscle cells in intracranial aneurysm by targeting CXCR3 and MMP-2
    Genet Mol Biol (2021) 44, e20200124-e20200124. PubMed  Europe PubMed DOI  PMC  EPMC
    60. 2020
  60. Amaral,A., Fernandes,C., Morazzo,S., Rebordao,M.R., Szostek-Mioduchowska,A., Lukasik,K., Gawronska-Kozak,B., Telo da Gama,L., Skarzynski,D.J. and Ferreira-Dias,G.
    The Inhibition of Cathepsin G on Endometrial Explants With Endometrosis in the Mare
    Front Vet Sci (2020) 7, 582211-582211. PubMed  Europe PubMed DOI  PMC  EPMC
  61. Azevedo Martins,J.M., Rabelo-Santos,S.H., do Amaral Westin,M.C. and Zeferino,L.C.
    Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis
    BMC Cancer (2020) 20, 660-660. PubMed  Europe PubMed DOI  PMC  EPMC
  62. Bai,X., Bai,G., Tang,L., Liu,L., Li,Y. and Jiang,W.
    Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis
    Exp Ther Med (2020) 20, 269-274. PubMed  Europe PubMed DOI  PMC  EPMC
  63. Baidya,S.K., Amin,S.A. and Jha,T.
    Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present
    Eur J Med Chem (2020) , 113044-113044. PubMed  Europe PubMed DOI  V
  64. Bakshi,J., Goyal,A.K., Singh,V., Sannigrahi,M. and Khullar,M.
    Stage-specific expression analysis ofMMP-2 & MMP-9 in laryngeal carcinoma
    J Cancer Res Ther (2020) 16, 517-520. PubMed  Europe PubMed DOI
  65. Barbe,A.M., Berbets,A.M., Davydenko,I.S., Koval,H.D., Yuzko,V.O. and Yuzko,O.M.
    Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
    J Med Life (2020) 13, 314-320. PubMed  Europe PubMed DOI  PMC  EPMC
  66. Becker,D.P., Lutz,M.R., Flieger,S., Colorina,A., Wozny,J. and Hosmane,N.S.
    Carborane-containing Matrix Metalloprotease (MMP) Ligands as Candidates for Boron Neutron Capture Therapy (BNCT)
    ChemMedChem (2020) PubMed  Europe PubMed DOI  I
  67. Bollmann,M., Pinno,K., Ehnold,L.I., Martens,N., Martson,A., Pap,T., Starke,C., Lohmann,C.H. and Bertrand,J.
    MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity
    Osteoarthritis Cartilage (2020) PubMed  Europe PubMed DOI  K
  68. Carrilho,M.R., Scaffa,P., Oliveira,V., Tjaderhane,L., Tersariol,I.L., Pashley,D.H., Tay,F. and Nascimento,F.D.
    Insights into cathepsin-B activity in mature dentin matrix
    Arch Oral Biol (2020) 117, 104830-104830. PubMed  Europe PubMed DOI
  69. Cheeran,V. and Munuswamy-Ramanujam,G.
    Sesquiterpene lactone Zaluzanin D alters MMP-9 promoter methylation in differentiated THP-1 monocytic cells and down regulates inflammatory cytokines IL-1beta and TNF-alpha
    Int Immunopharmacol (2020) 87, 106803-106803. PubMed  Europe PubMed DOI
  70. Chen,Z., Zhang,F., Zhang,S. and Ma,L.
    The down-regulation of SNCG inhibits the proliferation and invasiveness of human bladder cancer cell line 5637 and suppresses the expression of MMP-2/9
    Int J Clin Exp Pathol (2020) 13, 1873-1879. PubMed  Europe PubMed  PMC  EPMC  K
  71. de Figueiredo,F.A.T., Azevedo,J.P., Lara,M.G., Meschiari,C.A., Issa,J.P.M., Gerlach,R.F. and Lamano,T.C.L.
    Recombinant human MMP-2 associated with monoolein improves bone repair
    Bratisl Lek Listy (2020) 121, 571-579. PubMed  Europe PubMed DOI
  72. Dofara,S.G., Chang,S.L. and Diorio,C.
    Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk
    Anticancer Res (2020) 40, 3619-3631. PubMed  Europe PubMed DOI
  73. Dong,Z., Guo,S., Wang,Y., Zhang,J., Luo,H., Zheng,G., Yang,D., Zhang,T., Yan,L., Song,L., Liu,K., Sun,Z., Meng,X., Zheng,Z., Zhang,J. and Zhao,Y.
    USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer
    Onco Targets Ther (2020) 13, 8495-8510. PubMed  Europe PubMed DOI  PMC  EPMC  L
  74. Drishya,G., Nambiar,J., Shaji,S.K., Vanuopadath,M., Achuthan,A., Kumar,A., Alias,A., Sherif,A., Joseph,C., Divya,P., Kumar,D.S., Bose,C., Nair,S.V., Sudarslal,S., Kumar,G.B., Lakshmi,S. and Nair,B.G.
    RECK and TIMP-2 mediate inhibition of MMP-2 and MMP-9 by Annona muricata
    J Biosci (2020) 45 PubMed  Europe PubMed
  75. El-Hussieny,M., Mohammed,E.M., Zenhom,N.M., Refaie,M.M., Okasha,A.M. and Tawab,M.A.E.
    Possible Role of TGF-beta1, MMP-2, E-CAD, beta-Catenin and Antioxidants in Pathogenesis of Placenta Accreta
    Fetal Pediatr Pathol (2020) , 1-11. PubMed  Europe PubMed DOI
  76. Gou,X., Xue,Y., Zheng,H., Yang,G., Chen,S., Chen,Z. and Yuan,G.
    Gelatinases Cleave Dentin Sialoprotein Intracellularly
    Front Physiol (2020) 11, 686-686. PubMed  Europe PubMed DOI  PMC  EPMC  L
  77. Guo,W., Zhang,B., Sun,C., Duan,H.Q., Liu,W.X., Mu,K., Zhao,L., Li,H.R., Dong,Z.Y. and Cui,Q.
    Circular RNA derived from TIMP2 functions as a competitive endogenous RNA and regulates intervertebral disc degeneration by targeting miR1855p and matrix metalloproteinase 2
    Int J Mol Med (2020) 46, 621-632. PubMed  Europe PubMed DOI  PMC  EPMC
  78. Hazzaa,H.H., El Shiekh,M.A.M., Abdelgawad,N., Gouda,O.M. and Kamal,N.M.
    Correlation of VEGF and MMP-2 levels in oral lichen planus: An in vivo immunohistochemical study
    J Oral Biol Craniofac Res (2020) 10, 747-752. PubMed  Europe PubMed DOI  PMC  EPMC
  79. Huang,C.C., Wang,P.H., Lu,Y.T., Yang,J.S., Yang,S.F., Ho,Y.T., Lin,C.W. and Hsin,C.H.
    Morusin Suppresses Cancer Cell Invasion and MMP-2 Expression through ERK Signaling in Human Nasopharyngeal Carcinoma
    Molecules (2020) 25 PubMed  Europe PubMed DOI  PMC  EPMC
  80. Ji,J.J., Qian,L.L., Zhu,Y., Wu,Y.P., Guo,J.Q., Ma,G.S. and Yao,Y.Y.
    Serpina3c protects against high-fat diet-induced pancreatic dysfunction through the JNK-related pathway
    Cell Signal (2020) 75, 109745-109745. PubMed  Europe PubMed DOI
  81. Kaczorowska,A., Miekus,N., Stefanowicz,J. and Adamkiewicz-Drozynska,E.
    Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer
    Diagnostics (Basel) (2020) 10 PubMed  Europe PubMed DOI  V
  82. Ke,J.Y., Yang,J., Li,J., Xu,Z., Li,M.Q. and Zhu,Z.L.
    Baicalein inhibits FURIN-MT1-MMP-mediated invasion of ectopic endometrial stromal cells in endometriosis possibly by reducing the secretion of TGFB1
    Am J Reprod Immunol (2020) , e13344-e13344. PubMed  Europe PubMed DOI
  83. Kensara,A., Hefni,E., Williams,M.A., Saito,H., Mongodin,E. and Masri,R.
    Microbiological Profile and Human Immune Response Associated with Peri-Implantitis: A Systematic Review
    J Prosthodont (2020) PubMed  Europe PubMed DOI  V
  84. Kiani,A., Kamankesh,M., Vaisi-Raygani,A., Moradi,M.R., Tanhapour,M., Rahimi,Z., Elahi-Rad,S., Bahrehmand,F., Aliyari,M., Aghaz,F., Mozafari,H., Rezvani,N., Haghnazari,L. and Pourmotabbed,T.
    Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
    Mol Biol Rep (2020) PubMed  Europe PubMed DOI
  85. Kim,J. and Kim,M.M.
    Effect of Lapachol on the Inhibition of Matrix Metalloproteinase Related to the Invasion of Human Fibrosarcoma Cells
    Curr Mol Pharmacol (2020) PubMed  Europe PubMed DOI
  86. Lee,H., Kim,S.J., Shin,H. and Kim,Y.P.
    Collagen-immobilized extracellular FRET reporter for visualizing protease activity secreted by living cells
    ACS Sens (2020) 5, 655-664. PubMed  Europe PubMed DOI  L
  87. Lenci,E., Contini,A. and Trabocchi,A.
    Discovery of a d-pro-lys peptidomimetic inhibitor of MMP9: Addressing the gelatinase selectivity beyond S1' subsite
    Bioorg Med Chem Lett (2020) 30, 127467-127467. PubMed  Europe PubMed DOI
  88. Li,H., Ma,R.Q., Cheng,H.Y., Ye,X., Zhu,H.L. and Chang,X.H.
    Fibrinogen alpha chain (FGA) promotes the migration and invasion of human endometrial stromal cells in endometriosis through FAK/AKT/MMP-2 pathwaydagger
    Biol Reprod (2020) PubMed  Europe PubMed DOI
  89. Luo,W., Yu,Y., Wang,H., Liu,K., Wang,Y., Huang,M., Xuan,C., Li,Y. and Qi,J.
    Up-regulation of MMP-2 by histone H3K9 beta-hydroxybutyrylation to antagonize glomerulosclerosis in diabetic rat
    Acta Diabetol (2020) PubMed  Europe PubMed DOI
  90. Malik,A., Pal,R. and Gupta,S.K.
    EGF-mediated reduced miR-92a-1-5p controls HTR-8/SVneo cell invasion through activation of MAPK8 and FAS which in turn increase MMP-2/-9 expression
    Sci Rep (2020) 10, 12274-12274. PubMed  Europe PubMed DOI  PMC  EPMC
  91. Miao,R., Dong,X., Gong,J., Wang,Y., Guo,X., Li,Y., Liu,M., Wan,J., Li,J., Yang,S., Wang,W., Kuang,T., Zhong,J., Zhai,Z. and Yang,Y.
    hsa-miR-106b-5p participates in the development of chronic thromboembolic pulmonary hypertension via targeting matrix metalloproteinase 2
    Pulm Circ (2020) 10, 2045894020928300-2045894020928300. PubMed  Europe PubMed DOI  PMC  EPMC
  92. Morales-Vasquez,F., Castillo-Sanchez,R., Gomora,M.J., Almaraz,M.A., Pedernera,E., Perez-Montiel,D., Rendon,E., Lopez-Basave,H.N., Roman-Basaure,E., Cuevas-Covarrubias,S., Maldonado-Cubas,J., Villa,A. and Mendez,C.
    Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
    J Ovarian Res (2020) 13, 86-86. PubMed  Europe PubMed DOI  PMC  EPMC
  93. Nie,S., Lou,L., Wang,J., Cui,J., Wu,W., Zhang,Q., Liu,Y., Su,L., Chang,Y., Guo,W., Shen,H., Xing,L. and Li,Y.
    Expression, association with clinicopathological features and prognostic potential of CEP55, p-Akt, FoxM1 and MMP-2 in astrocytoma
    Oncol Lett (2020) 20, 1685-1694. PubMed  Europe PubMed DOI  PMC  EPMC
  94. Nogueira,M.E., Sousa Neto,I.V., Motta-Santos,D., Cantuaria,A.P.C., Lima,S.M.F., Rezende,T.M.B., Santana,H.A.P., Petriz,B.A., Marqueti,R.C. and Almeida,J.A.
    High-protein diet associated with resistance training reduces cardiac TNF-alpha levels and up-regulates MMP-2 activity in rats
    Arch Physiol Biochem (2020) , 1-7. PubMed  Europe PubMed DOI
  95. Olsman,M., Sereti,V., Andreassen,K., Snipstad,S., van Wamel,A., Eliasen,R., Berg,S., Urquhart,A.J., Andresen,T.L. and Davies,C.L.
    Ultrasound-mediated delivery enhances therapeutic efficacy of MMP sensitive liposomes
    J Control Release (2020) 325, 121-134. PubMed  Europe PubMed DOI
  96. Omar,A.M., Bajorath,J., Ihmaid,S., Mohamed,H.M., El-Agrody,A.M., Mora,A., El-Araby,M.E. and Ahmed,H.E.A.
    Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects
    Bioorg Chem (2020) 101, 103992-103992. PubMed  Europe PubMed DOI  I
  97. Pan,S., Zhang,Z., Li,C. and Yang,D.
    Interleukin-25 regulates matrix metalloproteinase-2 and -9 expression in periodontal fibroblast cells through ERK and P38MAPK pathways
    Cell Biol Int (2020) PubMed  Europe PubMed DOI
  98. Qiao,Y., Zhan,C., Wang,C., Shi,X., Yang,J., He,X., Ji,E., Yu,Z., Yan,C. and Wu,H.
    MMP-2 sensitive poly(malic acid) micelles stabilized by pi-pi stacking enable high drug loading capacity
    J Mater Chem B (2020) 8, 8527-8535. PubMed  Europe PubMed DOI
  99. Singh,M.P., Sharma,C. and Kang,S.C.
    Morin hydrate attenuates adenine-induced renal fibrosis via targeting cathepsin D signaling
    Int Immunopharmacol (2020) 90, 107234-107234. PubMed  Europe PubMed DOI
  100. Song,X., Yang,W., Wu,C., Han,Y. and Lu,Y.
    USP9X promotes the proliferation, invasion and metastasis of liver cancer cells through regulating the JAK2/STAT3 signaling
    Oncol Lett (2020) 20, 2897-2905. PubMed  Europe PubMed DOI  PMC  EPMC  K
  101. Tjahajawati,S., Zulhazmi,A., Cahyanto,A., Mariam,M.S., Djustiana,N., Aripin,D., Usri,K. and Widyaputra,S.S.
    Matrix levels of metalloproteinase-2 (MMP-2) and toxicity evaluation of carbonate apatite-based endodontic sealer in rat subcutaneous implantation
    Heliyon (2020) 6, e04330-e04330. PubMed  Europe PubMed DOI  PMC  EPMC
  102. Vira,H.J., Pradhan,V.D., Umare,V.D., Chaudhary,A.K., Rajadhyksha,A.G., Nadkar,M.Y., Ghosh,K. and Nadkarni,A.H.
    Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients
    Neth J Med (2020) 78, 261-268. PubMed  Europe PubMed
  103. Voitiv,Y., Usenko,O., Dosenko,V., Dyadyk,O. and Dzhemiliev,A.
    ANALYSIS OF POLYMORPHISM OF MATRIX METALLOPROTEINASE-2 (C-1306
    Georgian Med News (2020) , 7-12. PubMed  Europe PubMed
  104. Wang,H., Huang,L., Wu,L., Lan,J., Feng,X., Li,P. and Peng,Y.
    The MMP-2/TIMP-2 system in Alzheimer disease
    CNS Neurol Disord Drug Targets (2020) 19, 402-416. PubMed  Europe PubMed DOI  V
  105. Wu,W.C., Lee,W.J., Lee,T.H., Chen,S.C. and Chen,C.Y.
    Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
    World J Diabetes (2020) 11, 252-260. PubMed  Europe PubMed DOI  PMC  EPMC
  106. Yang,B., Zhang,D., Qian,J. and Cheng,Y.
    Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-kappaB system
    Mol Cell Biochem (2020) 474, 199-208. PubMed  Europe PubMed DOI
  107. Yuan,J., Zhang,G., Li,X., Ma,Q., Cheng,W., Wang,W., Zhang,B., Hu,T. and Song,G.
    Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway
    Int J Mol Sci (2020) 21 PubMed  Europe PubMed DOI  PMC  EPMC  K
  108. Yue,Y., Hsiao,Y.W. and Zhou,J.B.
    Association between MMP/TIMP Levels in the Aqueous Humor and Plasma with Axial Lengths in Myopia Patients
    Biomed Res Int (2020) 2020, 2961742-2961742. PubMed  Europe PubMed DOI  PMC  EPMC
  109. Zhang,L., Cui,Y., Yang,Y., Wei,J., Liu,W., Cai,L., Wang,L., Zhang,D., Xie,J. and Cheng,L.
    The virulence factor GroEL promotes gelatinase secretion from cells in the osteoblast lineage: Implication for direct crosstalk between bacteria and adult cells
    Arch Oral Biol (2020) 122, 104991-104991. PubMed  Europe PubMed DOI  L
  110. Zhang,Y., Liu,H., Chen,Z., Yu,M., Li,J., Dong,H., Li,N., Ding,X., Ge,Y., Liu,C., Ma,T. and Gui,B.
    TLR4-mediated hippocampal MMP/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db/db mice
    Neurochem Int (2020) 140, 104818-104818. PubMed  Europe PubMed DOI
  111. Zhao,F., Wu,H., Reinach,P.S., Wu,Y., Zhai,Y., Lei,Y., Ma,L., Su,Y., Chen,Y., Li,F., Liu,X., Srinivasalu,N., Qu,J. and Zhou,X.
    Up-Regulation of Matrix Metalloproteinase-2 by Scleral Monocyte-Derived Macrophages Contributes to Myopia Development
    Am J Pathol (2020) 190, 1888-1908. PubMed  Europe PubMed DOI
  112. Zhou,Y. and He,C.
    Functional expression and purification of the untagged C-terminal domain of MMP-2 from Escherichia coli inclusion bodies
    Protein Expr Purif (2020) 176, 105726-105726. PubMed  Europe PubMed DOI
    113. 2019
  113. Abu Bakar,A.R., Ripen,A.M., Merican,A.F. and Mohamad,S.B.
    Enzymatic inhibitory activity of Ficus deltoidea leaf extract on matrix metalloproteinase-2, 8 and 9
    Nat Prod Res (2019) 33, 1765-1768. PubMed  Europe PubMed DOI  I
  114. Bai,P., Lyu,L., Yu,T., Zuo,C., Fu,J., He,Y., Wan,Q., Wan,N., Jia,D. and Lyu,A.
    Macrophage-derived legumain promotes pulmonary hypertension by activating the MMP (matrix metalloproteinase)-2/TGF (transforming growth factor)-beta1 signaling
    Arterioscler Thromb Vasc Biol (2019) 39, e130-e130. PubMed  Europe PubMed DOI
  115. Bertran,A., Khomiak,D., Konopka,A., Rejmak,E., Bulska,E., Seco,J., Kaczmarek,L., Tarrago,T. and Prades,R.
    Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors
    Bioorg Chem (2019) , 103365-103365. PubMed  Europe PubMed DOI  I
  116. Chan,B.Y.H., Roczkowsky,A., Cho,W.J., Poirier,M., Lee,T.Y.T., Mahmud,Z. and Schulz,R.
    Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury
    Basic Res Cardiol (2019) 114, 42-42. PubMed  Europe PubMed DOI
  117. Cook,R., Sarker,H. and Fernandez-Patron,C.
    Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition
    Can J Physiol Pharmacol (2019) 97, 486-492. PubMed  Europe PubMed DOI  K
  118. Fallata,A.M., Wyatt,R.A., Levesque,J.M., Dufour,A., Overall,C.M. and Crawford,B.D.
    Intracellular localization in zebrafish muscle and conserved sequence features suggest roles for gelatinase A moonlighting in sarcomere maintenance
    Biomedicines (2019) 7 PubMed  Europe PubMed DOI
  119. Hannocks,M.J., Zhang,X., Gerwien,H., Chashchina,A., Burmeister,M., Korpos,E., Song,J. and Sorokin,L.
    The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes
    Matrix Biol (2019) 75-76, 102-113. PubMed  Europe PubMed DOI
  120. Kanda,H., Shimamura,R., Koizumi-Kitajima,M. and Okano,H.
    Degradation of extracellular matrix by matrix metalloproteinase 2 is essential for the establishment of the blood-brain barrier in Drosophila
    iScience (2019) 16, 218-229. PubMed  Europe PubMed DOI  PMC  EPMC
  121. Laghezza,A., Luisi,G., Caradonna,A., Di Pizio,A., Piemontese,L., Loiodice,F., Agamennone,M. and Tortorella,P.
    Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors
    Bioorg Med Chem (2019) , 115257-115257. PubMed  Europe PubMed DOI  I
  122. Lian,Y.Y., He,H.H., Zhang,C.Z., Li,X.C. and Chen,Y.H.
    Functional characterization of a matrix metalloproteinase 2 gene in Litopenaeus vannamei
    Fish Shellfish Immunol (2019) 84, 404-413. PubMed  Europe PubMed DOI
  123. Lyu,Y., Xiao,Q., Yin,L., Yang,L. and He,W.
    Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis
    Signal Transduct Target Ther (2019) 4, 26-26. PubMed  Europe PubMed DOI  I
  124. Marturano,A., Hendrickx,M.L.V., Falcinelli,E., Sebastiano,M., Guglielmini,G., Hassanzadeh-Ghassabeh,G., Muyldermans,S., Declerck,P.J. and Gresele,P.
    Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools
    Nanomedicine (2019) 24, 102103-102103. PubMed  Europe PubMed DOI
  125. Sarker,H., Hardy,E., Haimour,A., Maksymowych,W.P., Botto,L.D. and Fernandez-Patron,C.
    Identification of fibrinogen as a natural inhibitor of MMP-2
    Sci Rep (2019) 9, 4340-4340. PubMed  Europe PubMed DOI
  126. Wang,H., Ma,Z. and Han,H.
    A novel impedance enhancer for amperometric biosensor based ultrasensitive detection of matrix metalloproteinase-2
    Bioelectrochemistry (2019) 130, 107324-107324. PubMed  Europe PubMed DOI  A
  127. Yin,L., Sun,H., Zhang,H., He,L., Qiu,L., Lin,J., Xia,H., Zhang,Y., Ji,S., Shi,H. and Gao,M.
    Quantitatively visualizing tumor-related protease activity in vivo using a ratiometric photoacoustic probe
    J Am Chem Soc (2019) 141, 3265-3273. PubMed  Europe PubMed DOI  L
  128. Yin,L., Sun,H., Zhao,M., Wang,A., Qiu,S., Gao,Y., Ding,J., Ji,S.J., Shi,H. and Gao,M.
    Rational design and synthesis of a metalloproteinase-activatable probe for dual-modality imaging of metastatic lymph nodes in vivo
    J Org Chem (2019) 84, 6126-6133. PubMed  Europe PubMed DOI  L
    129. 2018
  129. Bencsik,P., Kupai,K., Gorbe,A., Kenyeres,E., Varga,Z.V., Paloczi,J., Gaspar,R., Kovacs,L., Weber,L., Takacs,F., Hajdu,I., Fabo,G., Cseh,S., Barna,L., Csont,T., Csonka,C., Dorman,G. and Ferdinandy,P.
    Development of matrix metalloproteinase-2 inhibitors for cardioprotection
    Front Pharmacol (2018) 9, 296-296. PubMed  Europe PubMed DOI  PMC  EPMC  I
  130. Beutel,B., Song,J., Konken,C.P., Korpos,E., Schinor,B., Gerwien,H., Vidyadharan,R., Burmeister,M., Li,L., Haufe,G. and Sorokin,L.
    New in vivo compatible matrix metalloproteinase (MMP)-2 and MMP-9 inhibitors
    Bioconjug Chem (2018) 29, 3715-3725. PubMed  Europe PubMed DOI  I
  131. Cao,S., Li,Z., Zhao,J., Chen,M. and Ma,N.
    Rational engineering a multichannel upconversion sensor for multiplex detection of matrix metalloproteinase activities
    ACS Sens (2018) 3, 1522-1530. PubMed  Europe PubMed DOI  L
  132. Cowell,S., Carroll,L., Lavdas,I., Aboagye,E.O. and Vilar,R.
    Towards an MMP-2-activated molecular agent for cancer imaging
    Dalton Trans (2018) 47, 1530-1534. PubMed  Europe PubMed DOI  L
  133. Gioia,M., Fasciglione,G.F., Sbardella,D., Sciandra,F., Casella,M., Camerini,S., Crescenzi,M., Gori,A., Tarantino,U., Cozza,P., Brancaccio,A., Coletta,M. and Bozzi,M.
    The enzymatic processing of alpha-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site
    PLoS ONE (2018) 13, e0192651-e0192651. PubMed  Europe PubMed DOI
  134. Jha,T., Adhikari,N., Saha,A. and Amin,S.A.
    Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors
    SAR QSAR Environ Res (2018) 29, 43-68. PubMed  Europe PubMed DOI  I
  135. Kim,I.Y., Kim,S.S., Lee,H.W., Bae,S.S., Ha,H.K., Jung,E.S., Lee,M.Y., Han,M., Rhee,H., Seong,E.Y., Lee,D.W., Lee,S.B., Lovett,D.H. and Song,S.H.
    The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus
    BMC Nephrol (2018) 19, 248-248. PubMed  Europe PubMed DOI  PMC  EPMC
  136. Kuwabara,Y., Kobayashi,T., D'Alessandro-Gabazza,C.N., Toda,M., Yasuma,T., Nishihama,K., Takeshita,A., Fujimoto,H., Nagao,M., Fujisawa,T. and Gabazza,E.C.
    Role of matrix metalloproteinase-2 in eosinophil-mediated airway remodeling
    Front Immunol (2018) 9, 2163-2163. PubMed  Europe PubMed DOI  PMC  EPMC
  137. Li,X.
    Gelatinase inhibitors: a patent review (2011-2017)
    Expert Opin Ther Pat (2018) 28, 31-46. PubMed  Europe PubMed DOI  V  I
  138. Liu,C., Li,S., Gu,Y., Xiong,H., Wong,W.T. and Sun,L.
    Multispectral photoacoustic imaging of tumor protease activity with a gold nanocage-based activatable probe
    Mol Imaging Biol (2018) 20, 919-929. PubMed  Europe PubMed DOI  A  L
  139. Liu,J.W. and Chen,D.Q.
    Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: a case-control study
    Kaohsiung J Med Sci (2018) 34, 634-642. PubMed  Europe PubMed DOI  M
  140. Mangiatordi,G.F., Guzzo,T., Rossano,E.C., Trisciuzzi,D., Alberga,D., Fasciglione,G., Coletta,M., Topai,A. and Nicolotti,O.
    Design, synthesis, and biological evaluation of tetrahydro-beta-carboline derivatives as selective sub-nanomolar gelatinase inhibitors
    ChemMedChem (2018) 13, 1343-1352. PubMed  Europe PubMed DOI  I
  141. Nadolski,G.J., Hunt,S.J., Weber,C.N., Mohammed,M., Pulido,S., Noji,M., Chisholm,A. and Gade,T.P.F.
    Near-infrared fluorescence imaging of matrix metalloproteinase 2 activity as a biomarker of vascular remodeling in hemodialysis access
    J Vasc Interv Radiol (2018) 29, 1268-1275. PubMed  Europe PubMed DOI  L
  142. Shamsara,J.
    Identification of non-zinc binding inhibitors of MMP-2 through virtual screening and subsequent rescoring
    Drug Res (Stuttg) (2018) 68, 529-535. PubMed  Europe PubMed DOI  I
  143. Tauro,M. and Lynch,C.C.
    Cutting to the chase: how matrix metalloproteinase-2 activity controls breast-cancer-to-bone metastasis
    Cancers (Basel) (2018) 10 PubMed  Europe PubMed DOI
  144. Zhang,H., Wang,X., Mao,J., Huang,Y., Xu,W., Duan,Y. and Zhang,J.
    Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity
    Bioorg Med Chem (2018) 26, 4363-4374. PubMed  Europe PubMed DOI  I
    145. 2017
  145. Adhikari,N., Mukherjee,A., Saha,A. and Jha,T.
    Arylsulfonamides and selectivity of matrix metalloproteinase-2: an overview
    Eur J Med Chem (2017) 129, 72-109. PubMed  Europe PubMed DOI  V  I
  146. Almalki,S.G., Llamas Valle,Y. and Agrawal,D.K.
    MMP-2 and MMP-14 silencing inhibits VEGFR2 cleavage and induces the differentiation of porcine adipose-derived mesenchymal stem cells to endothelial cells
    Stem Cells Transl Med (2017) 6, 1385-1398. PubMed  Europe PubMed DOI  K
  147. Ceron,C.S., Baligand,C., Joshi,S., Wanga,S., Cowley,P.M., Walker,J.P., Song,S.H., Mahimkar,R., Baker,A.J., Raffai,R.L., Wang,Z.J. and Lovett,D.H.
    An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury
    Am J Physiol Renal Physiol (2017) 312, F1166-F1183. PubMed  Europe PubMed DOI
  148. Cheng,H., Li,S.Y., Zheng,H.R., Li,C.X., Xie,B.R., Chen,K.W., Li,B. and Zhang,X.Z.
    Multi-Forster resonance energy transfer-based fluorescent probe for spatiotemporal matrix metalloproteinase-2 and caspase-3 imaging
    Anal Chem (2017) 89, 4349-4354. PubMed  Europe PubMed DOI  L
  149. Chowdhury,A., Nandy,S.K., Sarkar,J., Chakraborti,T. and Chakraborti,S.
    Inhibition of pro-/active MMP-2 by green tea catechins and prediction of their interaction by molecular docking studies
    Mol Cell Biochem (2017) 427, 111-122. PubMed  Europe PubMed DOI  I
  150. Kim,S.S., Shin,N., Bae,S.S., Lee,M.Y., Rhee,H., Kim,I.Y., Seong,E.Y., Lee,D.W., Lee,S.B., Kwak,I.S., Lovett,D.H. and Song,S.H.
    Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy
    PLoS ONE (2017) 12, e0171625-e0171625. PubMed  Europe PubMed DOI
  151. Mukherjee,A., Adhikari,N. and Jha,T.
    A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line
    Eur J Med Chem (2017) 141, 37-50. PubMed  Europe PubMed DOI  I
  152. Pillai,S.S., Yukawa,H., Onoshima,D., Biju,V. and Baba,Y.
    Forster resonance energy transfer mediated photoluminescence quenching in stoichiometrically assembled CdSe/ZnS quantum dot-peptide labeled black hole quencher conjugates for matrix metalloproteinase-2 sensing
    Anal Sci (2017) 33, 137-142. PubMed  Europe PubMed DOI  L
  153. Tauro,M., Shay,G., Sansil,S.S., Laghezza,A., Tortorella,P., Neuger,A.M., Soliman,H. and Lynch,C.C.
    Bone-seeking matrix metalloproteinase-2 inhibitors prevent bone metastatic breast cancer growth
    Mol Cancer Ther (2017) 16, 494-505. PubMed  Europe PubMed DOI  I
  154. Zhu,X., Lin,H., Wang,L., Tang,X., Ma,L., Chen,Z. and Gao,J.
    Activatable T1 relaxivity recovery nanoconjugates for kinetic and sensitive analysis of matrix metalloprotease 2
    ACS Appl Mater Interfaces (2017) 9, 21688-21696. PubMed  Europe PubMed DOI  L
    155. 2016
  155. Adhikari,N., Halder,A.K., Mallick,S., Saha,A., Saha,K.D. and Jha,T.
    Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays
    Bioorg Med Chem (2016) 24, 4291-4309. PubMed  Europe PubMed DOI  I
  156. Ammazzalorso,A., De Filippis,B., Campestre,C., Laghezza,A., Marrone,A., Amoroso,R., Tortorella,P. and Agamennone,M.
    Seeking for non-zinc-binding MMP-2 inhibitors: synthesis, biological evaluation and molecular modelling studies
    Int J Mol Sci (2016) 17 PubMed  Europe PubMed DOI  PMC  EPMC  I
  157. Bae,M.J., Karadeniz,F., Lee,S.G., Seo,Y. and Kong,C.S.
    Inhibition of MMP-2 and MMP-9 activities by Limonium tetragonum extract
    Prev Nutr Food Sci (2016) 21, 38-43. PubMed  Europe PubMed DOI  PMC  EPMC  I
  158. Beber,A.R., Polina,E.R., Biolo,A., Santos,B.L., Gomes,D.C., La Porta,V.L., Olsen,V., Clausell,N., Rohde,L.E. and Santos,K.G.
    Matrix metalloproteinase-2 polymorphisms in chronic heart failure: relationship with susceptibility and long-term survival
    PLoS ONE (2016) 11, e0161666-e0161666. PubMed  Europe PubMed DOI  M
  159. Bourguet,E., Brazhnik,K., Sukhanova,A., Moroy,G., Brassart-Pasco,S., Martin,A.P., Villena,I., Bellon,G., Sapi,J. and Nabiev,I.
    Design, synthesis, and use of MMP-2 inhibitor-conjugated quantum dots in functional biochemical assays
    Bioconjug Chem (2016) 27, 1067-1081. PubMed  Europe PubMed DOI  L  I
  160. Dang,Q., Gao,H., Li,Z., Qi,H., Gao,Q. and Zhang,C.
    Simple and sensitive electrogenerated chemiluminescence peptide-based biosensor for detection of matrix metalloproteinase 2 released from living cells
    Anal Bioanal Chem (2016) 408, 7067-7075. PubMed  Europe PubMed DOI  A  L
  161. Gao,M., Zhang,H., Trivedi,A., Mahasenan,K.V., Schroeder,V.A., Wolter,W.R., Suckow,M.A., Mobashery,S., Noble-Haeusslein,L.J. and Chang,M.
    Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury
    ACS Chem Neurosci (2016) 7, 1482-1487. PubMed  Europe PubMed DOI  I
  162. Gerwien,H., Hermann,S., Zhang,X., Korpos,E., Song,J., Kopka,K., Faust,A., Wenning,C., Gross,C.C., Honold,L., Melzer,N., Opdenakker,G., Wiendl,H., Schafers,M. and Sorokin,L.
    Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier
    Sci Transl Med (2016) 8, 364ra152-364ra. PubMed  Europe PubMed DOI  L
  163. He,W., Jiang,J., Yu,Z.Q. and Zhou,J.H.
    Novel 5-hydroxy, 5-substituted benzenesulfonamide pyrimidine-2,4,6-triones attenuate lipopolysaccharide-induced acute lung injury via inhibition of the gelatinases, MMP-2 and MMP-9
    Drug Dev Res (2016) 77, 251-257. PubMed  Europe PubMed DOI  I
  164. Jha,S., Kanaujia,S.P. and Limaye,A.M.
    Direct inhibition of matrix metalloproteinase-2 (MMP-2) by (-)-epigallocatechin-3-gallate: a possible role for the fibronectin type II repeats
    Gene (2016) 593, 126-130. PubMed  Europe PubMed DOI  I
  165. Joshi,S.K., Lee,L., Lovett,D.H., Kang,H., Kim,H.T., Delgado,C. and Liu,X.
    Novel intracellular N-terminal truncated matrix metalloproteinase-2 isoform in skeletal muscle ischemia-reperfusion injury
    J Orthop Res (2016) 34, 502-509. PubMed  Europe PubMed DOI
  166. Jun-Zhang, Wang,X.-J., Dong,Z.-K., Wang,S.-Q., Xu,W.-R., Fu,J.-W., Cheng,X.-C. and Wang,R.-L.
    CoMFA/CoMSIA and molecular docking studies of novel matrix metalloproteinase- 2 inhibitors based on l-tyrosine scaffold
    Lett Drug Des Discov (2016) 13, 376-386.  I
  167. Khrenova,M.G., Solovyev,I.D., Azev,V.N., Lapshin,G.D. and Savitsky,A.P.
    Oxoethylene derivative of the natural substrate as an inhibitor of matrix metalloproteinase MMP-2
    Mendeleev Commun (2016) 26, 207-208. DOI  I
  168. Lemmens,K., Hove,I.V. and Moons,L.
    Complementary research in mammals and fish indicates MMP-2 as a pleiotropic contributor to optic nerve regeneration
    Neural Regen Res (2016) 11, 740-742. PubMed  Europe PubMed DOI  PMC  EPMC
  169. Nambiar,J., Bose,C., Venugopal,M., Banerji,A., Patel,T.B., Kumar,G.B. and Nair,B.G.
    Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK
    Exp Cell Res (2016) 349, 139-151. PubMed  Europe PubMed DOI  I
  170. Vasilevskaya,T., Khrenova,M.G., Nemukhin,A.V. and Thiel,W.
    Methodological aspects of QM/MM calculations: a case study on matrix metalloproteinase-2
    J Comput Chem (2016) 37, 1801-1809. PubMed  Europe PubMed DOI  S
  171. Wang,D., Yuan,Y., Zheng,Y., Chai,Y. and Yuan,R.
    An electrochemical peptide cleavage-based biosensor for matrix metalloproteinase-2 detection with exonuclease III-assisted cycling signal amplification
    Chem Commun (Camb) (2016) 52, 5943-5945. PubMed  Europe PubMed DOI  A
  172. Xi,G., Wang,X. and Chen,T.
    A reduced graphene oxide-based fluorescence resonance energy transfer sensor for highly sensitive detection of matrix metalloproteinase 2
    Int J Nanomedicine (2016) 11, 1537-1547. PubMed  Europe PubMed DOI  PMC  EPMC  A
  173. Yang,J.K., Kwak,S.Y., Jeon,S.J., Lee,E., Ju,J.M., Kim,H.I., Lee,Y.S. and Kim,J.H.
    Proteolytic disassembly of peptide-mediated graphene oxide assemblies for turn-on fluorescence sensing of proteases
    Nanoscale (2016) 8, 12272-12281. PubMed  Europe PubMed DOI  A
  174. Zhang,L., Ren,R. and Mu,S.
    The correlation of MMP-2 polymorphisms and stroke
    Int J Clin Exp Med (2016) 9, 4460-4466.  M
    175. 2015
  175. Abbasi,M., Ramezani,F., Elyasi,M., Sadeghi-Aliabadi,H. and Amanlou,M.
    A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
    Daru (2015) 23, 29- PubMed  Europe PubMed DOI  PMC  EPMC  I
  176. Bauters,D., Scroyen,I., Van Hul,M. and Lijnen,H.R.
    Gelatinase A (MMP-2) promotes murine adipogenesis
    Biochim Biophys Acta (2015) 1850, 1449-1456. PubMed  Europe PubMed DOI  K
  177. Behrends,M., Wagner,S., Kopka,K., Schober,O., Schafers,M., Kumbhar,S., Waller,M. and Haufe,G.
    New matrix metalloproteinase inhibitors based on gamma-fluorinated alpha-aminocarboxylic and alpha-aminohydroxamic acids
    Bioorg Med Chem (2015) 23, 3809-3818. PubMed  Europe PubMed DOI  I
  178. Bianchini,F., Calugi,C., Ruzzolini,J., Menchi,G., Calorini,L., Guarna,A. and Trabocchi,A.
    A study of a d-proline peptidomimetic inhibitor of melanoma and endothelial cell invasion through activity towards MMP-2 and MMP-9
    MedChemComm (2015) 6, 277-282. DOI  I
  179. Diaz,N. and Suarez,D.
    Extensive simulations of the full-length matrix metalloproteinase-2 enzyme in a prereactive complex with a collagen triple-helical peptide
    Biochemistry (2015) 54, 1243-1258. PubMed  Europe PubMed DOI
  180. Gasparovic,I., Cizmarevic,N.S., Lovrecic,L., Perkovic,O., Lavtar,P., Sepcic,J., Jazbec,S.S., Kapovic,M., Peterlin,B. and Ristic,S.
    MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
    J Neuroimmunol (2015) 286, 13-15. PubMed  Europe PubMed DOI  M
  181. Gupta,B., Mai,K., Lowe,S.B., Wakefield,D., Di Girolamo,N., Gaus,K., Reece,P.J. and Gooding,J.J.
    Ultrasensitive and specific measurement of protease activity using functionalized photonic crystals
    Anal Chem (2015) 87, 9946-9953. PubMed  Europe PubMed DOI  A
  182. Hadler-Olsen,E., Solli,A.I., Hafstad,A., Winberg,J.O. and Uhlin-Hansen,L.
    Intracellular MMP-2 activity in skeletal muscle is associated with type II fibers
    J Cell Physiol (2015) 230, 160-169. PubMed  Europe PubMed DOI
  183. Liu,Q., Pan,D., Cheng,C., Zhang,A., Ma,C., Wang,L., Zhang,D., Liu,H., Jiang,H., Wang,T., Xu,Y., Yang,R., Chen,F., Yang,M. and Zuo,C.
    Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide
    Nucl Med Biol (2015) 42, 939-944. PubMed  Europe PubMed DOI  L
  184. Nanjan,P., Nambiar,J., Nair,B.G. and Banerji,A.
    Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9
    Bioorg Med Chem (2015) 23, 3781-3787. PubMed  Europe PubMed DOI  I
  185. Nuti,E., Cantelmo,A.R., Gallo,C., Bruno,A., Bassani,B., Camodeca,C., Tuccinardi,T., Vera,L., Orlandini,E., Nencetti,S., Stura,E.A., Martinelli,A., Dive,V., Albini,A. and Rossello,A.
    N-O-Isopropyl sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors: hit selection and in vivo antiangiogenic activity
    J Med Chem (2015) 58, 7224-7240. PubMed  Europe PubMed DOI  I
  186. Santamaria,S., Nuti,E., Cercignani,G., La Regina,G., Silvestri,R., Supuran,C.T. and Rossello,A.
    Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors
    J Enzyme Inhib Med Chem (2015) 30, 947-954. PubMed  Europe PubMed DOI  I
  187. Shen,M., Lee,J., Basu,R., Sakamuri,S.S., Wang,X., Fan,D. and Kassiri,Z.
    Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm
    Arterioscler Thromb Vasc Biol (2015) 35, 888-898. PubMed  Europe PubMed DOI  K
  188. Tveitaras,M.K., Skogstrand,T., Leh,S., Helle,F., Iversen,B.M., Chatziantoniou,C., Reed,R.K. and Hultstrom,M.
    Matrix metalloproteinase-2 knockout and heterozygote mice are protected from hydronephrosis and kidney fibrosis after unilateral ureteral obstruction
    PLoS ONE (2015) 10, e0143390-e0143390. PubMed  Europe PubMed DOI  K
  189. Vasilevskaya,T., Khrenova,M.G., Nemukhin,A.V. and Thiel,W.
    Mechanism of proteolysis in matrix metalloproteinase-2 revealed by QM/MM modeling
    J Comput Chem (2015) 36, 1621-1630. PubMed  Europe PubMed DOI
  190. Wang,P.F., Qiu,H.Y., Baloch,S.K., Gong,H.B., Wang,Z.C. and Zhu,H.L.
    Synthesis, biological evaluation, and docking of dihydropyrazole sulfonamide containing 2-hydroxyphenyl moiety: a series of novel MMP-2 inhibitors
    Chem Biol Drug Des (2015) 86, 1405-1410. PubMed  Europe PubMed DOI  I
  191. Wang,X., Berry,E., Hernandez-Anzaldo,S., Sun,D., Adijiang,A., Li,L., Zhang,D. and Fernandez-Patron,C.
    MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 cells
    FEBS Lett (2015) 589, 490-496. PubMed  Europe PubMed DOI
  192. Wanga,S., Ceron,C.S., Delgado,C., Joshi,S.K., Spaulding,K., Walker,J.P., Song,S., Olson,J.L. and Lovett,D.H.
    Two distinct isoforms of matrix metalloproteinase-2 are associated with human delayed kidney graft function
    PLoS ONE (2015) 10, e0136276-e0136276. PubMed  Europe PubMed DOI  R
  193. Yan,X.Q., Wang,Z.C., Li,Z., Wang,P.F., Qiu,H.Y., Chen,L.W., Lu,X.Y., Lv,P.C. and Zhu,H.L.
    Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: design, synthesis, inhibitory activity and 3D-QSAR analysis
    Bioorg Med Chem Lett (2015) 25, 4664-4671. PubMed  Europe PubMed DOI  I
  194. Zapico,J.M., Puckowska,A., Filipiak,K., Coderch,C., de Pascual-Teresa,B. and Ramos,A.
    Design and synthesis of potent hydroxamate inhibitors with increased selectivity within the gelatinase family
    Org Biomol Chem (2015) 13, 142-156. PubMed  Europe PubMed DOI  I
    195. 2014
  195. Bencsik,P., Paloczi,J., Kocsis,G.F., Pipis,J., Belecz,I., Varga,Z.V., Csonka,C., Gorbe,A., Csont,T. and Ferdinandy,P.
    Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective
    Pharmacol Res (2014) 80, 36-42. PubMed  Europe PubMed DOI  I
  196. Ekbote,A.V., Danda,S., Zankl,A., Mandal,K., Maguire,T. and Ungerer,K.
    Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene - a case report and review of the literature
    J Clin Res Pediatr Endocrinol (2014) 6, 40-46. PubMed  Europe PubMed DOI  M
  197. Fabre,B., Filipiak,K., Diaz,N., Zapico,J.M., Suarez,D., Ramos,A. and de Pascual-Teresa,B.
    An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily
    Chembiochem (2014) 15, 399-412. PubMed  Europe PubMed DOI  I
  198. Fan,G.C., Han,L., Zhu,H., Zhang,J.R. and Zhu,J.J.
    Ultrasensitive photoelectrochemical immunoassay for matrix metalloproteinase-2 detection based on CdS:Mn/CdTe cosensitized TiO2 nanotubes and signal amplification of SiO2@Ab2 conjugates
    Anal Chem (2014) 86, 12398-12405. PubMed  Europe PubMed DOI  A  L
  199. Filipiak,K., Kubinski,K., Hellman,U., Ramos,A. and de Pascual-Teresa,B.
    Human protein kinase CK2 phosphorylates matrix metalloproteinase 2 and inhibits its activity
    Chembiochem (2014) 15, 1873-1876. PubMed  Europe PubMed DOI
  200. Gaublomme,D., Buyens,T., De Groef,L., Stakenborg,M., Janssens,E., Ingvarsen,S., Porse,A., Behrendt,N. and Moons,L.
    Matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase co-regulate axonal outgrowth of mouse retinal ganglion cells
    J Neurochem (2014) 129, 966-979. PubMed  Europe PubMed DOI
  201. Hua,D., Kong,W., Zheng,X., Zhou,Z., Yu,B., Li,Y., Wang,Y., Yang,X., Liu,C., Tang,L., Li,Y. and Gong,M.
    Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics
    Drug Des Devel Ther (2014) 8, 1839-1849. PubMed  Europe PubMed DOI  PMC  EPMC
  202. Hughes,B.G., Fan,X., Cho,W.J. and Schulz,R.
    MMP-2 is localized to the mitochondria-associated membrane of the heart
    Am J Physiol Heart Circ Physiol (2014) 306, H764-H770. PubMed  Europe PubMed DOI
  203. Iwao,Y., Shiga,K., Shiroshita,A., Yoshikawa,T., Sakiie,M., Ueno,T., Ueno,S., Ijiri,T.W. and Sato,K.-I.
    The need of MMP-2 on the sperm surface for Xenopus fertilization: its role in a fast electrical block to polyspermy
    Mech Dev (2014) 134, 80-95. PubMed  Europe PubMed DOI
  204. Kang,S.G., Araya-Secchi,R., Wang,D., Wang,B., Huynh,T. and Zhou,R.
    Dual inhibitory pathways of metallofullerenol Gd@C82(OH)22 on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine
    Sci Rep (2014) 4, 4775-4775. PubMed  Europe PubMed DOI  PMC  EPMC  I
  205. Kuntze,L.B., Antonio,R.C., Izidoro-Toledo,T.C., Meschiari,C.A., Tanus-Santos,J.E. and Gerlach,R.F.
    Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations
    Basic Clin Pharmacol Toxicol (2014) 114, 233-239. PubMed  Europe PubMed DOI  I
  206. Lauer,J.L., Bhowmick,M., Tokmina-Roszyk,D., Lin,Y., Van Doren,S.R. and Fields,G.B.
    The role of collagen charge clusters in the modulation of matrix metalloproteinase activity
    J Biol Chem (2014) 289, 1981-1992. PubMed  Europe PubMed DOI  P
  207. Marcial,B.L., Sousa,S.F., Santos,H.F. and Ramos,M.J.
    Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs)
    J Biomol Struct Dyn (2014) 32, 1907-1918. PubMed  Europe PubMed DOI  I
  208. Qiu,H.-Y., Wang,Z.-C., Wang,P.-F., Yan,X.-Q., Wang,X.-M., Yang,Y.-H. and Zhu,H.-L.
    Design, synthesis, evaluation and 3D-QSAR analysis of benzosulfonamide benzenesulfonates as potent and selective inhibitors of MMP-2
    RSC Adv (2014) 4, 39214-39225. DOI  I
  209. Rossano,R., Larocca,M., Riviello,L., Coniglio,M.G., Vandooren,J., Liuzzi,G.M., Opdenakker,G. and Riccio,P.
    Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
    J Cell Mol Med (2014) 18, 242-252. PubMed  Europe PubMed DOI
  210. van Duijnhoven,S.M., Robillard,M.S., Hermann,S., Kuhlmann,M.T., Schafers,M., Nicolay,K. and Grull,H.
    Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes
    Mol Pharm (2014) 11, 1415-1423. PubMed  Europe PubMed DOI  L
  211. Verma,A., Rizvi,S.M., Shaikh,S., Ansari,M.A., Shakil,S., Ghazal,F., Siddiqui,M.H., Haneef,M. and Rehman,A.
    Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): an oncoinformatics study
    Pharmacogn Mag (2014) 10, 18-26. PubMed  Europe PubMed DOI  PMC  EPMC  I
  212. Wang,C., Zhan,C.L., Cai,Q.F., Du,C.H., Liu,G.M., Su,W.J. and Cao,M.J.
    Expression and characterization of common carp (Cyprinus carpio) matrix metalloproteinase-2 and its activity against type I collagen
    J Biotechnol (2014) 177, 45-52. PubMed  Europe PubMed DOI
  213. Wang,Z., Li,X., Feng,D., Li,L., Shi,W. and Ma,H.
    Poly(m-phenylenediamine)-based fluorescent nanoprobe for ultrasensitive detection of matrix metalloproteinase 2
    Anal Chem (2014) 86, 7719-7725. PubMed  Europe PubMed DOI  A  L
  214. Wu,J.L., Ge,S.Y., Cai,Z.X., Liu,H., Liu,Y.X., Wang,J.H. and Zhang,Q.Q.
    Purification and characterization of a gelatinolytic matrix metalloproteinase from the skeletal muscle of grass carp (Ctenopharyngodon idellus)
    Food Chem (2014) 145, 632-638. PubMed  Europe PubMed DOI
  215. Yari,K., Rahimi,Z., Moradi,M.T. and Rahimi,Z.
    The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer
    Asian Pac J Cancer Prev (2014) 15, 6199-6203. PubMed  Europe PubMed  M
  216. Yari,K., Rahimi,Z., Moradi,M.-T. and Rahimi,Z.
    The MMP-2-735 C allele is a risk factor for susceptibility to breast cancer
    Asian Pac J Cancer Prev (2014) 15, 6199-6203. DOI  M
  217. Yue,X., Wang,Z., Zhu,L., Wang,Y., Qian,C., Ma,Y., Kiesewetter,D.O., Niu,G. and Chen,X.
    Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS
    Mol Pharm (2014) 11, 4208-4217. PubMed  Europe PubMed DOI  L
  218. Zhang,J., Li,X., Jiang,Y., Feng,J., Li,X., Zhang,Y. and Xu,W.
    Design, synthesis and preliminary evaluation of alpha-sulfonyl gamma-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors
    Bioorg Med Chem (2014) 22, 3055-3064. PubMed  Europe PubMed DOI  I
  219. Zhang,X., Bresee,J., Cheney,P.P., Xu,B., Bhowmick,M., Cudic,M., Fields,G.B. and Edwards,W.B.
    Evaluation of a triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity
    Molecules (2014) 19, 8571-8588. PubMed  Europe PubMed DOI  L
  220. Zhang,X., Bresee,J., Fields,G.B. and Edwards,W.B.
    Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo
    Bioorg Med Chem Lett (2014) 24, 3786-3790. PubMed  Europe PubMed DOI  L
    221. 2013
  221. Alcantara,M.B. and Dass,C.R.
    Regulation of MT1-MMP and MMP-2 by the serpin PEDF: a promising new target for metastatic cancer
    Cell Physiol Biochem (2013) 31, 487-494. PubMed  Europe PubMed DOI
  222. Casalini,F., Fugazza,L., Esposito,G., Cabella,C., Brioschi,C., Cordaro,A., D'Angeli,L., Bartoli,A., Filannino,A.M., Gringeri,C.V., Longo,D.L., Muzio,V., Nuti,E., Orlandini,E., Figlia,G., Quattrini,A., Tei,L., Digilio,G., Rossello,A. and Maiocchi,A.
    Synthesis and preliminary evaluation in tumor bearing mice of new (18)F-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography
    J Med Chem (2013) 56, 2676-2689. PubMed  Europe PubMed DOI  L  I
  223. Castro,M.M., Fuah,J., Ali,M., Sung,M., Schulz,J., Kondo,M.Y., Fan,X., Holt,A. and Schulz,R.
    Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2
    Biochem Pharmacol (2013) 86, 469-475. PubMed  Europe PubMed DOI  I
  224. Diaz,N., Suarez,D. and Valdes,H.
    Unraveling the molecular structure of the catalytic domain of matrix metalloproteinase-2 in complex with a triple-helical peptide by means of molecular dynamics simulations
    Biochemistry (2013) 52, 8556-8569. PubMed  Europe PubMed DOI
  225. Fabre,B., Filipiak,K., Zapico,J.M., Diaz,N., Carbajo,R.J., Schott,A.K., Martinez-Alcazar,M.P., Suarez,D., Pineda-Lucena,A., Ramos,A. and de Pascual-Teresa,B.
    Progress towards water-soluble triazole-based selective MMP-2 inhibitors
    Org Biomol Chem (2013) 11, 6623-6641. PubMed  Europe PubMed DOI  I
  226. Freskos,J.N., Asmelash,B., Gaston,K.R., Karwa,A., Marzan,T.A., Nickols,M.A., Rogers,T.E., Schoenstein,T., Sympson,C.J. and Vu,B.
    Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes
    Bioorg Med Chem Lett (2013) 23, 5566-5570. PubMed  Europe PubMed DOI  L  I
  227. Givvimani,S., Kundu,S., Narayanan,N., Armaghan,F., Qipshidze,N., Pushpakumar,S., Vacek,T.P. and Tyagi,S.C.
    TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure
    Arch Physiol Biochem (2013) 119, 65-74. PubMed  Europe PubMed DOI  K
  228. Gooyit,M., Song,W., Mahasenan,K.V., Lichtenwalter,K., Suckow,M.A., Schroeder,V.A., Wolter,W.R., Mobashery,S. and Chang,M.
    O-Phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier
    J Med Chem (2013) 56, 8139-8150. PubMed  Europe PubMed DOI  I
  229. Halder,A.K., Saha,A. and Jha,T.
    Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors
    J Pharm Pharmacol (2013) 65, 1541-1554. PubMed  Europe PubMed DOI  I
  230. Higashi,S., Hirose,T., Takeuchi,T. and Miyazaki,K.
    Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2)
    J Biol Chem (2013) 288, 9066-9076. PubMed  Europe PubMed DOI
  231. Hugenberg,V., Riemann,B., Hermann,S., Schober,O., Schafers,M., Szardenings,K., Lebedev,A., Gangadharmath,U., Kolb,H., Walsh,J., Zhang,W., Kopka,K. and Wagner,S.
    Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (Radio)synthesis, in vitro and first in vivo evaluation
    J Med Chem (2013) 56, 6858-6870. PubMed  Europe PubMed DOI  I
  232. Jacob-Ferreira,A.L. and Schulz,R.
    Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species: consequences and therapeutic strategies in the heart
    Arch Biochem Biophys (2013) 540, 82-93. PubMed  Europe PubMed DOI
  233. Ji,M.K., Shi,Y., Xu,J.W., Lin,X. and Lin,J.Y.
    Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities
    Anticancer Drugs (2013) 24, 461-472. PubMed  Europe PubMed DOI  E  U
  234. Kreituss,I., Rozenberga,E., Zemitis,J., Trapencieris,P., Romanchikova,N. and Turks,M.
    Discovery of aziridine-triazole conjugates as selective MMP-2 inhibitors
    Chem Heterocycl Compd (2013) 49, 1108-1117. DOI  I
  235. Lovett,D.H., Mahimkar,R., Raffai,R.L., Cape,L., Zhu,B.Q., Jin,Z.Q., Baker,A.J. and Karliner,J.S.
    N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure
    PLoS ONE (2013) 8, e68154-e68154. PubMed  Europe PubMed DOI  PMC  EPMC
  236. Marques,S.M., Abate,C.C., Chaves,S., Marques,F., Santos,I., Nuti,E., Rossello,A. and Santos,M.A.
    New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy
    J Inorg Biochem (2013) 127, 188-202. PubMed  Europe PubMed DOI  I
  237. Pizio,A.D., Laghezza,A., Tortorella,P. and Agamennone,M.
    Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors
    ChemMedChem (2013) 8, 1475-1482. PubMed  Europe PubMed DOI  I
  238. Rastogi,A., Kim,H., Twomey,J.D. and Hsieh,A.H.
    MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc
    Arthritis Res Ther (2013) 15, R57-R57. PubMed  Europe PubMed DOI
  239. Ryu,J.H., Shin,J.Y., Kim,S.A., Kang,S.W., Kim,H., Kang,S., Choi,K., Kwon,I.C., Kim,B.S. and Kim,K.
    Non-invasive optical imaging of matrix metalloproteinase activity with albumin-based fluorogenic nanoprobes during angiogenesis in a mouse hindlimb ischemia model
    Biomaterials (2013) 34, 6871-6881. PubMed  Europe PubMed DOI  L
  240. Shi,Z.H., Li,N.G., Shi,Q.P., Tang,H., Tang,Y.P., Li,W., Yin,L., Yang,J.P. and Duan,J.A.
    Design, synthesis and biological evaluation of ferulic acid amides as selective matrix metalloproteinase inhibitors
    Med Chem (2013) 9, 947-954. PubMed  Europe PubMed DOI  I
  241. Takahashi,T., Fujimori,C., Hagiwara,A. and Ogiwara,K.
    Recent advances in the understanding of teleost medaka ovulation: the roles of proteases and prostaglandins
    Zoolog Sci (2013) 30, 239-247. PubMed  Europe PubMed DOI
  242. Tauro,M., Laghezza,A., Loiodice,F., Agamennone,M., Campestre,C. and Tortorella,P.
    Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors
    Bioorg Med Chem (2013) 21, 6456-6465. PubMed  Europe PubMed DOI  I
  243. Verslegers,M., Lemmens,K., Van Hove,I. and Moons,L.
    Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system
    Prog Neurobiol (2013) 105, 60-78. PubMed  Europe PubMed DOI  V
  244. Yoon,H.K. and Yoo,T.H.
    A novel protease activity assay method based on an engineered autoinhibited protein using an enzyme-linked immunoassay
    Analyst (2013) 138, 7164-7168. PubMed  Europe PubMed DOI  A
  245. Zheng,T., Zhang,R., Zhang,Q., Tan,T., Zhang,K., Zhu,J.J. and Wang,H.
    Ultrasensitive dual-channel detection of matrix metalloproteinase-2 in human serum using gold-quantum dot core-satellite nanoprobes
    Chem Commun (Camb) (2013) 49, 7881-7883. PubMed  Europe PubMed DOI  A
  246. Zhong,H.A., Arbiser,J. and Bowen,J.P.
    Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors
    Curr Pharm Des (2013) 19, 4701-4713. PubMed  Europe PubMed DOI  I
    247. 2012
  247. Alam,M., Ali,S.A., Abbasi,A., Kalbacher,H. and Voelter,W.
    Design and synthesis of a peptidyl-FRET substrate for tumor marker enzyme human matrix metalloprotease-2 (hMMP-2)
    Int J Pept Res Ther (2012) 18, 207-215. DOI  A
  248. Ali,M.A., Chow,A.K., Kandasamy,A.D., Fan,X., West,L.J., Crawford,B.D., Simmen,T. and Schulz,R.
    Mechanisms of cytosolic targeting of matrix metalloproteinase-2
    J Cell Physiol (2012) 227, 3397-3404. PubMed  Europe PubMed DOI
  249. Bu,Z., Pan,Y., Shang,B., Cao,Z., Zhou,Q. and Ruan,C.
    SZ-117, a monoclonal antibody against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis
    Hybridoma (Larchmt) (2012) 31, 63-67. PubMed  Europe PubMed DOI
  250. Burkhart,J.L., Diehl,B., Schmitt,M.J. and Kazmaier,U.
    A straightforward approach to MMP-2 and MMP-9 inhibitors based on chelate claisen rearrangements
    Eur J Org Chem (2012) 2012, 567-575. DOI  I
  251. Cheng,X.C., Wang,R.L., Dong,Z.K., Li,J., Li,Y.Y. and Li,R.R.
    Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
    Bioorg Med Chem (2012) 20, 5738-5744. PubMed  Europe PubMed DOI  I
  252. Christianson,C.A., Fitzsimmons,B.L., Shim,J.H., Agrawal,A., Cohen,S.M., Hua,X.Y. and Yaksh,T.L.
    Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism
    Neuroscience (2012) 200, 199-210. PubMed  Europe PubMed DOI  I
  253. Chuang,C.H., Chuang,K.H., Wang,H.E., Roffler,S.R., Shiea,J.T., Tzou,S.C., Cheng,T.C., Kao,C.H., Wu,S.Y., Tseng,W.L., Cheng,C.M., Hou,M.F., Wang,J.M. and Cheng,T.L.
    In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate
    Clin Cancer Res (2012) 18, 238-247. PubMed  Europe PubMed DOI  L
  254. de Melo,E.B.
    A QSAR study of matrix metalloproteinases type 2 (MMP-2) inhibitors with cinnamoyl pyrrolidine derivatives
    Sci Pharm (2012) 80, 265-281. PubMed  Europe PubMed DOI  PMC  EPMC  I
  255. Detry,B., Erpicum,C., Paupert,J., Blacher,S., Maillard,C., Bruyere,F., Pendeville,H., Remacle,T., Lambert,V., Balsat,C., Ormenese,S., Lamaye,F., Janssens,E., Moons,L., Cataldo,D., Kridelka,F., Carmeliet,P., Thiry,M., Foidart,J.M., Struman,I. and Noel,A.
    Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase
    Blood (2012) 119, 5048-5056. PubMed  Europe PubMed DOI
  256. Di Pizio,A., Agamennone,M. and Aschi,M.
    An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors
    PLoS ONE (2012) 7, e47774-e47774. PubMed  Europe PubMed DOI  PMC  EPMC  I
  257. Frankowski,H., Gu,Y.H., Heo,J.H., Milner,R. and del Zoppo,G.J.
    Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures
    Methods Mol Biol (2012) 814, 221-233. PubMed  Europe PubMed DOI  A
  258. Harney,A.S., Sole,L.B. and Meade,T.J.
    Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase2 by a Co(III) Schiff base complex
    J Biol Inorg Chem (2012) 17, 853-860. PubMed  Europe PubMed DOI  I
  259. Koo,B.H., Kim,Y.H., Han,J.H. and Kim,D.S.
    Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation
    J Biol Chem (2012) 287, 22643-22653. PubMed  Europe PubMed DOI
  260. Lacchini,R., Jacob-Ferreira,A.L., Luizon,M.R., Gasparini,S., Ferreira-Sae,M.C., Schreiber,R., Nadruz,W., Jr. and Tanus-Santos,J.E.
    Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
    J Hum Hypertens (2012) 26, 171-177. PubMed  Europe PubMed DOI  M
  261. Marcial,B.L., Sousa,S.F., Barbosa,I.L., Dos Santos,H.F. and Ramos,M.J.
    Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study
    J Phys Chem B (2012) 116, 13644-13654. PubMed  Europe PubMed DOI  I
  262. Mikhailova,M., Xu,X., Robichaud,T.K., Pal,S., Fields,G.B. and Steffensen,B.
    Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2)
    Matrix Biol (2012) 31, 380-388. PubMed  Europe PubMed DOI
  263. Murphy,G.
    Matrix metallopeptidase-2/gelatinase A
    [ISSN:978-0-12-407744-7] (2012) 3, 747-753. DOI
  264. Nicolotti,O., Catto,M., Giangreco,I., Barletta,M., Leonetti,F., Stefanachi,A., Pisani,L., Cellamare,S., Tortorella,P., Loiodice,F. and Carotti,A.
    Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9
    Eur J Med Chem (2012) 58, 368-376. PubMed  Europe PubMed DOI  I
  265. Peng,H., Wu,Y., Duan,Z., Ciborowski,P. and Zheng,J.C.
    Proteolytic processing of SDF-1alpha by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration
    Protein Cell (2012) 3, 875-882. PubMed  Europe PubMed DOI
  266. Rah,B., Amin,H., Yousuf,K., Khan,S., Jamwal,G., Mukherjee,D. and Goswami,A.
    A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4
    PLoS ONE (2012) 7, e44039-e44039. PubMed  Europe PubMed DOI  PMC  EPMC  I
  267. Serra,P., Bruczko,M., Zapico,J.M., Puckowska,A., Garcia,M.A., Martin-Santamari,S., Ramos,A. and de Pascual-Teresa,B.
    MMP-2 selectivity in hydroxamate-type inhibitors
    Curr Med Chem (2012) 19, 1036-1064. PubMed  Europe PubMed  I
  268. Shi,Z.H., Li,N.G., Shi,Q.P., Hao,T. and Tang,Y.P.
    Design, synthesis, and preliminary evaluation of substituted cinnamic acid esters as selective matrix metalloproteinase inhibitors
    Drug Dev Res (2012) 73, 317-324. DOI  I
  269. Tanakit,A., Rouffet,M., Martin,D.P. and Cohen,S.M.
    Investigating chelating sulfonamides and their use in metalloproteinase inhibitors
    Dalton Trans (2012) 41, 6507-6515. PubMed  Europe PubMed DOI  I
  270. Thiolloy,S., Edwards,J.R., Fingleton,B., Rifkin,D.B., Matrisian,L.M. and Lynch,C.C.
    An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment
    PLoS ONE (2012) 7, e29862-e29862. PubMed  Europe PubMed DOI  PMC  EPMC
  271. Topai,A., Breccia,P., Minissi,F., Padova,A., Marini,S. and Cerbara,I.
    In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors
    Bioorg Med Chem (2012) 20, 2323-2337. PubMed  Europe PubMed DOI  I
  272. Verhille,M., Benachour,H., Ibrahim,A., Achard,M., Arnoux,P., Barberi-Heyob,M., Andre,J.C., Allonas,X., Baros,F., Vanderesse,R. and Frochot,C.
    Photodynamic molecular beacons triggered by MMP-2 and MMP-9: influence of the distance between photosensitizer and quencher onto photophysical properties and enzymatic activation
    Curr Med Chem (2012) 19, 5580-5594. PubMed  Europe PubMed DOI  A
  273. Wang,N., Zhu,M., Tsao,S.W., Man,K., Zhang,Z. and Feng,Y.
    Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma
    PLoS ONE (2012) 7, e46318-e46318. PubMed  Europe PubMed DOI  PMC  EPMC
  274. Wang,Y., Shen,P., Li,C., Wang,Y. and Liu,Z.
    Upconversion fluorescence resonance energy transfer based biosensor for ultrasensitive detection of matrix metalloproteinase-2 in blood
    Anal Chem (2012) 84, 1466-1473. PubMed  Europe PubMed DOI  A
  275. Yamamoto,D., Takai,S., Akimoto,T., Hirahara,I., Ito,C., Muto,S. and Kusano,E.
    Matrix metalloproteinase-2 inhibition by temocapril and its important role in peritoneal transport
    Clin Exp Pharmacol Physiol (2012) 39, 864-868. PubMed  Europe PubMed DOI  I
  276. Yamamoto,N., Bryce,N.S., Metzler-Nolte,N. and Hambley,T.W.
    Effects of enzymatic activation on the distribution of fluorescently tagged MMP-2 cleavable peptides in cancer cells and spheroids
    Bioconjug Chem (2012) 23, 1110-1118. PubMed  Europe PubMed DOI
    277. 2011
  277. Choi,S.S., Ji,A.R., Yu,S.W., Cho,B.H., Park,J.D., Park,J.H., Lee,H.S., Ryu,S.E., Kim,D.H., Kang,J.H. and Lee,S.T.
    Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors
    Bull Korean Chem Soc (2011) 32, 2032-2038. DOI  I
  278. Diehl,B., Hoffmann,T.M., Mueller,N.C., Burkhart,J.L., Kazmaier,U. and Schmitt,M.J.
    Novel yeast bioassay for high-throughput screening of matrix metalloproteinase inhibitors
    Appl Environ Microbiol (2011) 77, 8573-8577. PubMed  Europe PubMed DOI  I
  279. Feng,D., Zhang,Y., Feng,T., Shi,W., Li,X. and Ma,H.
    A graphene oxide-peptide fluorescence sensor tailor-made for simple and sensitive detection of matrix metalloproteinase 2
    Chem Commun (Camb) (2011) 47, 10680-10682. PubMed  Europe PubMed DOI  A
  280. Giangreco,I., Lattanzi,G., Nicolotti,O., Catto,M., Laghezza,A., Leonetti,F., Stefanachi,A. and Carotti,A.
    Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations
    PLoS ONE (2011) 6, e25597-e25597. PubMed  Europe PubMed DOI  PMC  EPMC  I
  281. Jo,Y.K., Park,S.J., Shin,J.H., Kim,Y., Hwang,J.J., Cho,D.H. and Kim,J.C.
    ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells
    Biochem Biophys Res Commun (2011) 404, 1039-1043. PubMed  Europe PubMed DOI  I
  282. Liu,X.
    Emerging ideas: matrix metalloproteinase-2 in muscle atrophy
    Clin Orthop Relat Res (2011) 469, 1797-1799. PubMed  Europe PubMed DOI
  283. Moroy,G., Bourguet,E., Decarme,M., Sapi,J., Alix,A.J., Hornebeck,W. and Lorimier,S.
    Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)
    Biochem Pharmacol (2011) 81, 626-635. PubMed  Europe PubMed DOI  I
  284. Robichaud,T.K., Steffensen,B. and Fields,G.B.
    Exosite interactions impact matrix metalloproteinase collagen specificities
    J Biol Chem (2011) 286, 37535-37542. PubMed  Europe PubMed DOI  P
  285. Saygili,E., Schauerte,P., Pekassa,M., Saygili,E., Rackauskas,G., Schwinger,R.H.G., Weis,J., Weber,C., Marx,N. and Rana,O.R.
    Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion
    Cell Mol Neurobiol (2011) 31, 17-25. PubMed  Europe PubMed DOI
  286. Testero,S.A., Lee,M., Staran,R.T., Espahbodi,M., Llarrull,L.I., Toth,M., Mobashery,S. and Chang,M.
    Sulfonate-containing thiiranes as selective gelatinase inhibitors
    ACS Med Chem Lett (2011) 2, 177-181. PubMed  Europe PubMed DOI  I
  287. Testero,S.A., Llarrull,L.I., Fisher,J.F., Chang,M. and Mobashery,S.
    Exploring the functional space of thiiranes as gelatinase inhibitors using click chemistry
    Arkivoc (2011) 2011, 221-236.  I
  288. Tremblay,P., Beaudet,M.J., Tremblay,E., Rueda,N., Thomas,T. and Vallieres,L.
    Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair
    J Pathol (2011) 224, 222-233. PubMed  Europe PubMed DOI
  289. Wang,J., Medina,C., Radomski,M.W. and Gilmer,J.F.
    N-Substituted homopiperazine barbiturates as gelatinase inhibitors
    Bioorg Med Chem (2011) 19, 4985-4999. PubMed  Europe PubMed DOI  I
  290. Westermann,D., Savvatis,K., Lindner,D., Zietsch,C., Becher,P.M., Hammer,E., Heimesaat,M.M., Bereswill,S., Volker,U., Escher,F., Riad,A., Plendl,J., Klingel,K., Poller,W., Schultheiss,H.P. and Tschope,C.
    Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy
    Circulation (2011) 124, 2082-2093. PubMed  Europe PubMed DOI  K
  291. Wilson,L.J., Wang,B., Yang,S.M., Scannevin,R.H., Burke,S.L., Karnachi,P., Rhodes,K.J. and Murray,W.V.
    Discovery of novel cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy
    Bioorg Med Chem Lett (2011) 21, 6485-6490. PubMed  Europe PubMed DOI  I
  292. Xu,X., Mikhailova,M., Chen,Z., Pal,S., Robichaud,T.K., Lafer,E.M., Baber,S. and Steffensen,B.
    Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2)
    Matrix Biol (2011) 30, 404-412. PubMed  Europe PubMed DOI
  293. Zapico,J., Serra,P., Sanmartin,J.G., Filipiak,K., Martinez,A., Santamaria,S.M., de Pascual-Teresa,B. and Ramos,A.
    Synthesis of selective MMP-2 inhibitors using click chemistry
    An R Acad Farm (2011) 77, 99-117.  I
    294. 2010
  294. Ali,M.A., Cho,W.J., Hudson,B., Kassiri,Z., Granzier,H. and Schulz,R.
    Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury
    Circulation (2010) 122, 2039-2047. PubMed  Europe PubMed DOI
  295. Becker,D.P., Barta,T.E., Bedell,L.J., Boehm,T.L., Bond,B.R., Carroll,J., Carron,C.P., Decrescenzo,G.A., Easton,A.M., Freskos,J.N., Funckes-Shippy,C.L., Heron,M., Hockerman,S., Howard,C.P., Kiefer,J.R., Li,M.H., Mathis,K.J., McDonald,J.J., Mehta,P.P., Munie,G.E., Sunyer,T., Swearingen,C.A., Villamil,C.I., Welsch,D., Williams,J.M., Yu,Y. and Yao,J.
    Orally active MMP-1 sparing alpha-tetrahydropyranyl and alpha-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease
    J Med Chem (2010) 53, 6653-6680. PubMed  Europe PubMed DOI  I
  296. Bruni-Cardoso,A., Lynch,C.C., Rosa-Ribeiro,R., Matrisian,L.M. and Carvalho,H.F.
    MMP-2 contributes to the development of the mouse ventral prostate by impacting epithelial growth and morphogenesis
    Dev Dyn (2010) 239, 2386-2392. PubMed  Europe PubMed DOI  K
  297. Emara,M. and Wozniak,M.
    In vitro inhibition of human MMP-2 collagenolytic and gelatinolytic activity by neutralizing monoclonal antibodies
    Immunol Invest (2010) 39, 833-848. PubMed  Europe PubMed DOI
  298. Gioia,M., Fasciglione,G.F., Monaco,S., Iundusi,R., Sbardella,D., Marini,S., Tarantino,U. and Coletta,M.
    pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain
    J Biol Inorg Chem (2010) 15, 1219-1232. PubMed  Europe PubMed DOI
  299. Hernandez-Guillamon,M., Mawhirt,S., Fossati,S., Blais,S., Pares,M., Penalba,A., Boada,M., Couraud,P.O., Neubert,T.A., Montaner,J., Ghiso,J. and Rostagno,A.
    Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells
    J Biol Chem (2010) 285, 27144-27158. PubMed  Europe PubMed DOI
  300. Kim,J.H. and Chung,B.H.
    Proteolytic fluorescent signal amplification on gold nanoparticles for a highly sensitive and rapid protease assay
    Small (2010) 6, 126-131. PubMed  Europe PubMed DOI  A
  301. Linke,W.A.
    Molecular giant vulnerable to oxidative damage: titin joins the club of proteins degraded by matrix metalloproteinase-2
    Circulation (2010) 122, 2002-2004. PubMed  Europe PubMed DOI
  302. Manso,H., Krug,T., Sobral,J., Albergaria,I., Gaspar,G., Ferro,J.M., Oliveira,S.A. and Vicente,A.M.
    Variants of the matrix metalloproteinase-2 but not the matrix metalloproteinase-9 genes significantly influence functional outcome after stroke
    BMC Med Genet (2010) 11, 40-40. PubMed  Europe PubMed DOI  M
  303. Tao,P., Fisher,J.F., Shi,Q., Mobashery,S. and Schlegel,H.B.
    Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT
    J Phys Chem B (2010) 114, 1030-1037. PubMed  Europe PubMed DOI  I
  304. Ulmer,T.A., Keeler,V., Andre,S., Gabius,H.J., Loh,L. and Laferte,S.
    The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage
    Biochim Biophys Acta (2010) 1800, 336-343. PubMed  Europe PubMed DOI
    305. 2009
  305. Burns,D.M., Li,Y.L., Shi,E., He,C., Xu,M., Zhuo,J., Zhang,C., Qian,D.Q., Li,Y., Wynn,R., Covington,M.B., Katiyar,K., Marando,C.A., Fridman,J.S., Scherle,P., Friedman,S., Metcalf,B. and Yao,W.
    Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition
    Bioorg Med Chem Lett (2009) 19, 3525-3530. PubMed  Europe PubMed DOI  I
  306. Carvalho,R.V., Ogliari,F.A., de Souza,A.P., Silva,A.F., Petzhold,C.L., Line,S.R., Piva,E. and Etges,A.
    2-Hydroxyethyl methacrylate as an inhibitor of matrix metalloproteinase-2
    Eur J Oral Sci (2009) 117, 64-67. PubMed  Europe PubMed DOI  I
  307. Chaussain,C., Eapen,A.S., Huet,E., Floris,C., Ravindran,S., Hao,J., Menashi,S. and George,A.
    MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell
    Eur Cell Mater (2009) 18, 84-95. PubMed  Europe PubMed
  308. Forbes,C., Shi,Q., Fisher,J.F., Lee,M., Hesek,D., Llarrull,L.I., Toth,M., Gossing,M., Fridman,R. and Mobashery,S.
    Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases
    Chem Biol Drug Des (2009) 74, 527-534. PubMed  Europe PubMed DOI  PMC  EPMC  I
  309. Gooyit,M., Lee,M., Hesek,D., Boggess,B., Oliver,A.G., Fridman,R., Mobashery,S. and Chang,M.
    Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors
    Chem Biol Drug Des (2009) 74, 535-546. PubMed  Europe PubMed DOI  I
  310. Huang,H., Zhao,W., Tang,Z., Yang,S., Wu,Z., Zhao,S., Cui,W., Mu,Y., Chu,M. and Li,K.
    Characterization of porcine MMP-2 and its association with immune traits
    Gene (2009) 435, 63-71. PubMed  Europe PubMed DOI
  311. Jastrzebska,B., Lebel,R., Therriault,H., McIntyre,J.O., Escher,E., Guerin,B., Paquette,B., Neugebauer,W.A. and Lepage,M.
    New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging
    J Med Chem (2009) 52, 1576-1581. PubMed  Europe PubMed DOI  L
  312. Jung,J.C., Wang,P.X., Zhang,G., Ezura,Y., Fini,M.E. and Birk,D.E.
    Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation
    Cell Tissue Res (2009) 336, 79-89. PubMed  Europe PubMed DOI  PMC  EPMC
  313. Kenny,H.A. and Lengyel,E.
    MMP-2 functions as an early response protein in ovarian cancer metastasis
    Cell Cycle (2009) 8, 683-688. PubMed  Europe PubMed
  314. Lee,M., Celenza,G., Boggess,B., Blase,J., Shi,Q., Toth,M., Bernardo,M.M., Wolter,W.R., Suckow,M.A., Hesek,D., Noll,B.C., Fridman,R., Mobashery,S. and Chang,M.
    A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition
    Chem Biol Drug Des (2009) 73, 189-202. PubMed  Europe PubMed DOI  PMC  EPMC  I
  315. Lehmann,H.C., Kohne,A., Bernal,F., Jangouk,P., Meyer Zu Horste,G., Dehmel,T., Hartung,H.P., Previtali,S.C. and Kieseier,B.C.
    Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neurons
    Glia (2009) 57, 479-489. PubMed  Europe PubMed DOI
  316. Murnane,M.J., Cai,J., Shuja,S., McAneny,D., Klepeis,V. and Willett,J.B.
    Active MMP-2 effectively identifies the presence of colorectal cancer
    Int J Cancer (2009) 125, 2893-2902. PubMed  Europe PubMed DOI  PMC  EPMC
  317. Song,J.H., Kim,S.H., Cho,D., Lee,I.K., Kim,H.J. and Kim,T.S.
    Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2
    Int J Cancer (2009) 125, 1074-1081. PubMed  Europe PubMed DOI
  318. Tao,P., Fisher,J.F., Mobashery,S. and Schlegel,H.B.
    DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2
    Org Lett (2009) 11, 2559-2562. PubMed  Europe PubMed DOI  I
  319. Tao,P., Fisher,J.F., Shi,Q., Vreven,T., Mobashery,S. and Schlegel,H.B.
    Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue
    Biochemistry (2009) 48, 9839-9847. PubMed  Europe PubMed DOI  I
  320. Tuysuz,B., Mosig,R., Altun,G., Sancak,S., Glucksman,M.J. and Martignetti,J.A.
    A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects
    Eur J Hum Genet (2009) 17, 565-572. PubMed  Europe PubMed DOI  PMC  EPMC  M
  321. Viappiani,S., Nicolescu,A.C., Holt,A., Sawicki,G., Crawford,B.D., Leon,H., van Mulligen,T. and Schulz,R.
    Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione
    Biochem Pharmacol (2009) 77, 826-834. PubMed  Europe PubMed DOI
  322. Wang,W., Shao,R., Wu,Q., Ke,S., McMurray,J., Lang,F.F., Jr., Charnsangavej,C., Gelovani,J.G. and Li,C.
    Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide
    Mol Imaging Biol (2009) 11, 424-433. PubMed  Europe PubMed DOI  L  I
  323. Xu,X., Mikhailova,M., Ilangovan,U., Chen,Z., Yu,A., Pal,S., Hinck,A.P. and Steffensen,B.
    Nuclear magnetic resonance mapping and functional confirmation of the collagen binding sites of matrix metalloproteinase-2
    Biochemistry (2009) 48, 5822-5831. PubMed  Europe PubMed DOI  PMC  EPMC
  324. Zhi,Y.H., Song,M.M., Wang,P.L., Zhang,T. and Yin,Z.Y.
    Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion
    World J Gastroenterol (2009) 15, 1072-1078. PubMed  Europe PubMed DOI  PMC  EPMC  T
    325. 2008
  325. Celenza,G., Villegas-Estrada,A., Lee,M., Boggess,B., Forbes,C., Wolter,W.R., Suckow,M.A., Mobashery,S. and Chang,M.
    Metabolism of (4-phenoxyphenylsulfonyl) methylthiirane, a selective gelatinase inhibitor
    Chem Biol Drug Des (2008) 71, 187-196. PubMed  Europe PubMed DOI  I
  326. Cheng,X.C., Wang,Q., Fang,H., Tang,W. and Xu,W.F.
    Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors
    Eur J Med Chem (2008) 43, 2130-2139. PubMed  Europe PubMed DOI  I
  327. Diaz,N. and Suarez,D.
    Peptide hydrolysis catalyzed by matrix metalloproteinase 2: a computational study
    J Phys Chem B (2008) 112, 8412-8424. PubMed  Europe PubMed DOI
  328. Diaz,N., Suarez,D. and Valdes,H.
    From the X-ray compact structure to the elongated form of the full-length MMP-2 enzyme in solution: a molecular dynamics study
    J Am Chem Soc (2008) 130, 14070-14071. PubMed  Europe PubMed DOI  S
  329. Fert-Bober,J., Leon,H., Sawicka,J., Basran,R.S., Devon,R.M., Schulz,R. and Sawicki,G.
    Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion
    Basic Res Cardiol (2008) 103, 431-443. PubMed  Europe PubMed DOI
  330. Higashi,S. and Miyazaki,K.
    Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor
    J Biol Chem (2008) 283, 10068-10078. PubMed  Europe PubMed DOI
  331. Ingvarsen,S., Madsen,D.H., Hillig,T., Lund,L.R., Holmbeck,K., Behrendt,N. and Engelholm,L.H.
    Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells
    Biol Chem (2008) 389, 943-953. PubMed  Europe PubMed DOI
  332. Lebel,R., Jastrzebska,B., Therriault,H., Cournoyer,M.M., McIntyre,J.O., Escher,E., Neugebauer,W., Paquette,B. and Lepage,M.
    Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model
    Magn Reson Med (2008) 60, 1056-1065. PubMed  Europe PubMed DOI  L
  333. Lee,M., Hesek,D., Shi,Q., Noll,B.C., Fisher,J.F., Chang,M. and Mobashery,S.
    Conformational analyses of thiirane-based gelatinase inhibitors
    Bioorg Med Chem Lett (2008) 18, 3064-3067. PubMed  Europe PubMed DOI  I
  334. Mukai,T., Suganuma,N., Soejima,K., Sasaki,J., Yamamoto,F. and Maeda,M.
    Synthesis of a beta-tetrapeptide analog as a mother compound for the development of matrix metalloproteinase-2-imaging agents
    Chem Pharm Bull (Tokyo) (2008) 56, 260-265. PubMed  Europe PubMed DOI  L  I
  335. Naidu,D.G., Tang,M. and Tabibzadeh,S.
    Lefty peptides, derived by MMP2 cleavage, act as a new class of gelatinase A inhibitor
    Front Biosci (2008) 13, 7193-7201. PubMed  Europe PubMed
  336. Nishida,Y., Miyamori,H., Thompson,E.W., Takino,T., Endo,Y. and Sato,H.
    Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2
    Cancer Res (2008) 68, 9096-9104. PubMed  Europe PubMed DOI
  337. Rehault-Godbert,S., Gautron,J., Labas,V., Belghazi,M. and Nys,Y.
    Identification and characterization of the precursor of chicken matrix metalloprotease 2 (pro-MMP-2) in hen egg
    J Agric Food Chem (2008) 56, 6294-6303. PubMed  Europe PubMed DOI
  338. Tsung,A.J., Kargiotis,O., Chetty,C., Lakka,S.S., Gujrati,M., Spomar,D.G., Dinh,D.H. and Rao,J.S.
    Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model
    Int J Oncol (2008) 32, 557-564. PubMed  Europe PubMed  PMC  EPMC
  339. Yang,S.M., Scannevin,R.H., Wang,B., Burke,S.L., Huang,Z., Karnachi,P., Wilson,L.J., Rhodes,K.J., Lagu,B. and Murray,W.V.
    beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents
    Bioorg Med Chem Lett (2008) 18, 1140-1145. PubMed  Europe PubMed DOI  I
  340. Yang,S.M., Scannevin,R.H., Wang,B., Burke,S.L., Wilson,L.J., Karnachi,P., Rhodes,K.J., Lagu,B. and Murray,W.V.
    beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. design, synthesis, and lead identification
    Bioorg Med Chem Lett (2008) 18, 1135-1139. PubMed  Europe PubMed DOI  I
  341. Zheng,J., Wen,R. and Guillaume,D.
    Three-dimensional quantitative structure-activity relationship (CoMFA and CoMSIA) studies on galardin derivatives as gelatinase A (matrix metalloproteinase 2) inhibitors
    J Enzyme Inhib Med Chem (2008) 23, 445-453. PubMed  Europe PubMed DOI  I
    342. 2007
  342. Baraldo,S., Bazzan,E., Zanin,M.E., Turato,G., Garbisa,S., Maestrelli,P., Papi,A., Miniati,M., Fabbri,L.M., Zuin,R. and Saetta,M.
    Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression
    Chest (2007) 132, 1733-1740. PubMed  Europe PubMed DOI
  343. de Oliveira,C.A., Zissen,M., Mongon,J. and McCammon,J.A.
    Molecular dynamics simulations of metalloproteinases types 2 and 3 reveal differences in the dynamic behavior of the S1' binding pocket
    Curr Pharm Des (2007) 13, 3471-3475. PubMed  Europe PubMed DOI  I
  344. Diaz,N. and Suarez,D.
    Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions
    Biochemistry (2007) 46, 8943-8952. PubMed  Europe PubMed DOI
  345. Egeblad,M., Shen,H.C., Behonick,D.J., Wilmes,L., Eichten,A., Korets,L.V., Kheradmand,F., Werb,Z. and Coussens,L.M.
    Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development
    Dev Dyn (2007) 236, 1683-1693. PubMed  Europe PubMed DOI  PMC  EPMC  K  M
  346. Gioia,M., Monaco,S., Fasciglione,G.F., Coletti,A., Modesti,A., Marini,S. and Coletta,M.
    Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains
    J Mol Biol (2007) 368, 1101-1113. PubMed  Europe PubMed DOI
  347. Hanaoka,H., Mukai,T., Habashita,S., Asano,D., Ogawa,K., Kuroda,Y., Akizawa,H., Iida,Y., Endo,K., Saga,T. and Saji,H.
    Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors
    Nucl Med Biol (2007) 34, 503-510. PubMed  Europe PubMed DOI  L  I
  348. Hasebe,T., Hartman,R., Fu,L., Amano,T. and Shi,Y.B.
    Evidence for a cooperative role of gelatinase A and membrane type-1 matrix metalloproteinase during Xenopus laevis development
    Mech Dev (2007) 124, 11-22. PubMed  Europe PubMed DOI  PMC  EPMC
  349. Hayashi,R., Jin,X. and Cook,G.R.
    Synthesis and evaluation of novel heterocyclic MMP inhibitors
    Bioorg Med Chem Lett (2007) 17, 6864-6870. PubMed  Europe PubMed DOI  PMC  EPMC  I
  350. Iida,J., Wilhelmson,K.L., Ng,J., Lee,P., Morrison,C., Tam,E., Overall,C.M. and McCarthy,J.B.
    Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A)
    Biochem J (2007) 403, 553-563. PubMed  Europe PubMed DOI  PMC  EPMC
  351. Lauer-Fields,J., Brew,K., Whitehead,J.K., Li,S., Hammer,R.P. and Fields,G.B.
    Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors
    J Am Chem Soc (2007) 129, 10408-10417. PubMed  Europe PubMed DOI  PMC  EPMC  I
  352. Lee,M., Villegas-Estrada,A., Celenza,G., Boggess,B., Toth,M., Kreitinger,G., Forbes,C., Fridman,R., Mobashery,S. and Chang,M.
    Metabolism of a highly selective gelatinase inhibitor generates active metabolite
    Chem Biol Drug Des (2007) 70, 371-382. PubMed  Europe PubMed DOI  I
  353. Monaco,S., Gioia,M., Rodriguez,J., Fasciglione,G.F., Di Pierro,D., Lupidi,G., Krippahl,L., Marini,S. and Coletta,M.
    Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen
    Biochem J (2007) 402, 503-513. PubMed  Europe PubMed DOI  PMC  EPMC
  354. Mosig,R.A., Dowling,O., DiFeo,A., Ramirez,M.C., Parker,I.C., Abe,E., Diouri,J., Aqeel,A.A., Wylie,J.D., Oblander,S.A., Madri,J., Bianco,P., Apte,S.S., Zaidi,M., Doty,S.B., Majeska,R.J., Schaffler,M.B. and Martignetti,J.A.
    Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth
    Hum Mol Genet (2007) 16, 1113-1123. PubMed  Europe PubMed DOI  PMC  EPMC  K  M
  355. Taniwaki,K., Fukamachi,H., Komori,K., Ohtake,Y., Nonaka,T., Sakamoto,T., Shiomi,T., Okada,Y., Itoh,T., Itohara,S., Seiki,M. and Yana,I.
    Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice
    Cancer Res (2007) 67, 4311-4319. PubMed  Europe PubMed DOI
  356. Tsukamoto,H., Yokoyama,Y., Suzuki,T., Mizuta,S. and Yoshinaka,R.
    Molecular cloning and expression of gelatinases (MMP-2 and MMP-9) in the pufferfish Takifugu rubripes
    Comp Biochem Physiol B Biochem Mol Biol (2007) 148, 295-302. PubMed  Europe PubMed DOI
    357. 2006
  357. [YEAR:30-10-2006]Bellosta,S., Gomaraschi,M., Canavesi,M., Rossoni,G., Monetti,M., Franceschini,G. and Calabresi,L.
    Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection
    FEBS Lett (30-10-2006) 580, 5974-5978. PubMed  Europe PubMed DOI  T
  358. [YEAR:4-8-2006]Cheng,S., Pollock,A.S., Mahimkar,R., Olson,J.L. and Lovett,D.H.
    Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
    FASEB J (4-8-2006) 20, 1898-1900. PubMed  Europe PubMed DOI  T
  359. Greenlee,K.J., Corry,D.B., Engler,D.A., Matsunami,R.K., Tessier,P., Cook,R.G., Werb,Z. and Kheradmand,F.
    Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation
    J Immunol (2006) 177, 7312-7321. PubMed  Europe PubMed  PMC  EPMC
  360. [YEAR:18-1-2006]Hasebe,T., Hartman,R., Matsuda,H. and Shi,Y.B.
    Spatial and temporal expression profiles suggest the involvement of gelatinase A and membrane type 1 matrix metalloproteinase in amphibian metamorphosis
    Cell Tissue Res (18-1-2006) 324, 105-116. PubMed  Europe PubMed DOI
  361. [YEAR:27-2-2006]Matsusaka,H., Ide,T., Matsushima,S., Ikeuchi,M., Kubota,T., Sunagawa,K., Kinugawa,S. and Tsutsui,H.
    Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload
    Hypertension (27-2-2006) 47, 711-717. PubMed  Europe PubMed DOI  K
  362. Monaco,S., Sparano,V., Gioia,M., Sbardella,D., Di Pierro,D., Marini,S. and Coletta,M.
    Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains
    Protein Sci (2006) 15, 2805-2815. PubMed  Europe PubMed DOI  PMC  EPMC
  363. [YEAR:28-9-2006]Nakaji,K., Ihara,M., Takahashi,C., Itohara,S., Noda,M., Takahashi,R. and Tomimoto,H.
    Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents
    Stroke (28-9-2006) 37, 2816-2823. PubMed  Europe PubMed DOI  T  I
  364. Thompson,M. and Cockerill,G.
    Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis
    Ann N Y Acad Sci (2006) 1085, 170-174. PubMed  Europe PubMed DOI
  365. [YEAR:14-2-2006]Tuccinardi,T., Martinelli,A., Nuti,E., Carelli,P., Balzano,F., Uccello-Barretta,G., Murphy,G. and Rossello,A.
    Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides
    Bioorg Med Chem (14-2-2006) 14, 4260-4276. PubMed  Europe PubMed DOI  I
  366. [YEAR:7-6-2006]Yamamoto,S., Nakatani,S., Ikura,M., Sugiura,T., Nishita,Y., Itadani,S., Ogawa,K., Ohno,H., Takahashi,K., Nakai,H. and Toda,M.
    Design and synthesis of an orally active matrix metalloproteinase inhibitor
    Bioorg Med Chem (7-6-2006) 14, 6383-6403. PubMed  Europe PubMed DOI  I
  367. [YEAR:26-9-2006]Zhang,L., Zhang,J., Fang,H., Wang,Q. and Xu,W.
    Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors
    Bioorg Med Chem (26-9-2006) 14, 8286-8294. PubMed  Europe PubMed DOI  I
    368. 2005
  368. Agamennone,M., Campestre,C., Preziuso,S., Consalvi,V., Crucianelli,M., Mazza,F., Politi,V., Ragno,R., Tortorella,P. and Gallina,C.
    Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2
    Eur J Med Chem (2005) 40, 271-279. PubMed  Europe PubMed DOI  I
  369. Al-Aqeel,A.I.
    Al-Aqeel Sewairi syndrome, a new autosomal recessive disorder with multicentric osteolysis, nodulosis and arthropathy. The first genetic defect of matrix metalloproteinase 2 gene
    Saudi Med J (2005) 26, 24-30. PubMed  Europe PubMed  M
  370. Ben-Yosef,Y., Miller,A., Shapiro,S. and Lahat,N.
    Hypoxia of endothelial cells leads to MMP-2-dependent survival and death
    Am J Physiol Cell Physiol (2005) 289, C1321-C1331. PubMed  Europe PubMed DOI
  371. [YEAR:31-5-2005]Bianchini,G., Aschi,M., Cavicchio,G., Crucianelli,M., Preziuso,S., Gallina,C., Nastari,A., Gavuzzo,E. and Mazza,F.
    Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8
    Bioorg Med Chem (31-5-2005) 13, 4740-4749. PubMed  Europe PubMed DOI  I
  372. [YEAR:6-1-2005]Cao,J., Rehemtulla,A., Pavlaki,M., Kozarekar,P. and Chiarelli,C.
    Furin directly cleaves proMMP-2 in the trans-golgi network resulting in a nonfunctioning proteinase
    J Biol Chem (6-1-2005) 280, 10974-10980. PubMed  Europe PubMed DOI
  373. [YEAR:29-9-2005]Lee,M., Bernardo,M.M., Meroueh,S.O., Brown,S., Fridman,R. and Mobashery,S.
    Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors
    Org Lett (29-9-2005) 7, 4463-4465. PubMed  Europe PubMed DOI  I
  374. [YEAR:22-7-2005]Lindstad,R.I., Sylte,I., Mikalsen,S.O., Seglen,P.O., Berg,E. and Winberg,J.O.
    Pancreatic trypsin activates human promatrix metalloproteinase-2
    J Mol Biol (22-7-2005) 350, 682-698. PubMed  Europe PubMed DOI
  375. [YEAR:3-6-2005]Matsusaka,H., Ikeuchi,M., Matsushima,S., Ide,T., Kubota,T., Feldman,A.M., Takeshita,A., Sunagawa,K. and Tsutsui,H.
    Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy
    Am J Physiol Heart Circ Physiol (3-6-2005) 289, H1858-H1864. PubMed  Europe PubMed DOI
  376. Oblander,S.A., Zhou,Z., Galvez,B.G., Starcher,B., Shannon,J.M., Durbeej,M., Arroyo,A.G., Tryggvason,K. and Apte,S.S.
    Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation
    Dev Biol (2005) 277, 255-269. PubMed  Europe PubMed DOI
  377. [YEAR:1-3-2005]Rossello,A., Nuti,E., Carelli,P., Orlandini,E., Macchia,M., Nencetti,S., Zandomeneghi,M., Balzano,F., Uccello Barretta,G., Albini,A., Benelli,R., Cercignani,G., Murphy,G. and Balsamo,A.
    N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP
    Bioorg Med Chem Lett (1-3-2005) 15, 1321-1326. PubMed  Europe PubMed DOI  I
  378. [YEAR:26-7-2005]Sawicki,G., Leon,H., Sawicka,J., Sariahmetoglu,M., Schulze,C.J., Scott,P.G., Szczesna-Cordary,D. and Schulz,R.
    Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2
    Circulation (26-7-2005) 112, 544-552. PubMed  Europe PubMed DOI
  379. [YEAR:10-3-2005]Wang,F.Q., So,J., Reierstad,S. and Fishman,D.A.
    Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase
    Int J Cancer (10-3-2005) 114, 19-31. PubMed  Europe PubMed DOI
  380. [YEAR:12-7-2005]Xu,X., Chen,Z., Wang,Y., Yamada,Y. and Steffensen,B.
    Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2
    Biochem J (12-7-2005) 392, 127-134. PubMed  Europe PubMed DOI  PMC  EPMC
  381. Zankl,A., Bonafe,L., Calcaterra,V., Di Rocco,M. and Superti-Furga,A.
    Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2
    Clin Genet (2005) 67, 261-266. PubMed  Europe PubMed DOI  M
    382. 2004
  382. [YEAR:21-9-2004]Belkin,A.M., Zemskov,E.A., Hang,J., Akimov,S.S., Sikora,S. and Strongin,A.Y.
    Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis
    Biochemistry (21-9-2004) 43, 11760-11769. PubMed  Europe PubMed DOI
  383. [YEAR:19-1-2004]Butler,G.S., Tam,E.M. and Overall,C.M.
    The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing the role of the methionine-turn in the metzincin metalloprotease superfamily
    J Biol Chem (19-1-2004) 279, 15615-15620. PubMed  Europe PubMed DOI  I
  384. Duong,T.D. and Erickson,C.A.
    MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo
    Dev Dyn (2004) 229, 42-53. PubMed  Europe PubMed DOI
  385. Grieu,F., Li,W.Q. and Iacopetta,B.
    Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype
    Breast Cancer Res Treat (2004) 88, 197-204. PubMed  Europe PubMed DOI  M
  386. [YEAR:6-2-2004]Kwan,J.A., Schulze,C.J., Wang,W., Leon,H., Sariahmetoglu,M., Sung,M., Sawicka,J., Sims,D.E., Sawicki,G. and Schulz,R.
    Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro
    FASEB J (6-2-2004) 18, 690-692. PubMed  Europe PubMed DOI
  387. [YEAR:17-8-2004]Ma,Z., Chang,M.J., Shah,R., Adamski,J., Zhao,X. and Benveniste,E.N.
    Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene
    J Biol Chem (17-8-2004) 279, 46326-46334. PubMed  Europe PubMed DOI
  388. [YEAR:1-11-2004]Martinez,A., Oh,H.R., Unsworth,E.J., Bregonzio,C., Saavedra,J.M., Stetler-Stevenson,W.G. and Cuttitta,F.
    Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator
    Biochem J (1-11-2004) 383, 413-418. PubMed  Europe PubMed DOI  PMC  EPMC
  389. Murphy,G.
    Gelatinase A
    [ISSN:0-12-079610-4] (2004) 2, 497-503.  V
  390. [YEAR:28-9-2004]Oak,M.H., El Bedoui,J., Anglard,P. and Schini-Kerth,V.B.
    Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells
    Circulation (28-9-2004) 110, 1861-1867. PubMed  Europe PubMed DOI
  391. [YEAR:5-4-2004]Oh,J., Takahashi,R., Adachi,E., Kondo,S., Kuratomi,S., Noma,A., Alexander,D.B., Motoda,H., Okada,A., Seiki,M., Itoh,T., Itohara,S., Takahashi,C. and Noda,M.
    Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice
    Oncogene (5-4-2004) 23, 5041-5048. PubMed  Europe PubMed DOI  K
  392. [YEAR:1-5-2004]Rossello,A., Nuti,E., Orlandini,E., Carelli,P., Rapposelli,S., Macchia,M., Minutolo,F., Carbonaro,L., Albini,A., Benelli,R., Cercignani,G., Murphy,G. and Balsamo,A.
    New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2)
    Bioorg Med Chem (1-5-2004) 12, 2441-2450. PubMed  Europe PubMed DOI  I
  393. Svab,I., Alexandru,D., Vitos,G. and Flonta,M.L.
    Binding affinities for sulfonamide inhibitors with matrix metalloproteinase-2 using a linear response method
    J Cell Mol Med (2004) 8, 551-562. PubMed  Europe PubMed  I
  394. [YEAR:19-11-2004]Xu,E., Lai,M., Lv,B., Xing,X., Huang,Q. and Xia,X.
    A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer
    Biochem Biophys Res Commun (19-11-2004) 324, 999-1003. PubMed  Europe PubMed DOI  M
  395. [YEAR:21-2-2004]Zhang,W., Hou,T.J., Qiao,X.B., Huai,S. and Xu,X.J.
    Binding affinity of hydroxamate inhibitors of matrix metalloproteinase-2
    J Mol Model (21-2-2004) 10, 112-120. PubMed  Europe PubMed DOI  I
  396. [YEAR:16-12-2004]Zhao,H., Bernardo,M.M., Osenkowski,P., Sohail,A., Pei,D., Nagase,H., Kashiwagi,M., Soloway,P.D., DeClerck,Y.A. and Fridman,R.
    Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation
    J Biol Chem (16-12-2004) 279, 8592-8601. PubMed  Europe PubMed DOI  I
    397. 2003
  397. [YEAR:19-5-2003]Auge,F., Hornebeck,W., Decarme,M. and Laronze,J.Y.
    Improved gelatinase A selectivity by novel zinc binding groups containing galardin derivatives
    Bioorg Med Chem Lett (19-5-2003) 13, 1783-1786. PubMed  Europe PubMed DOI  I
  398. Chen,E.I., Li,W., Godzik,A., Howard,E.W. and Smith,J.W.
    A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9
    J Biol Chem (2003) 278, 17158-17163. PubMed  Europe PubMed DOI
  399. Cheng,D., Shen,Q., Nan,F., Qian,Z. and Ye,Q.Z.
    Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening
    Protein Expr Purif (2003) 27, 63-74. PubMed  Europe PubMed DOI  I
  400. Cheng,S. and Lovett,D.H.
    Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation
    Am J Pathol (2003) 162, 1937-1949. PubMed  Europe PubMed DOI  PMC  EPMC
  401. [YEAR:7-2-2003]Deshane,J., Garner,C.C. and Sontheimer,H.
    Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2
    J Biol Chem (7-2-2003) 278, 4135-4144. PubMed  Europe PubMed DOI
  402. [YEAR:6-6-2003]Harendza,S., Lovett,D.H., Panzer,U., Lukacs,Z., Kuhnl,P. and Stahl,R.A.
    Linked common polymorphisms in the gelatinase A promoter are associated with diminished transcriptional response to estrogen and genetic fitness
    J Biol Chem (6-6-2003) 278, 20490-20499. PubMed  Europe PubMed DOI  M
  403. Hayashidani,S., Tsutsui,H., Ikeuchi,M., Shiomi,T., Matsusaka,H., Kubota,T., Imanaka-Yoshida,K., Itoh,T. and Takeshita,A.
    Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction
    Am J Physiol Heart Circ Physiol (2003) 285, H1229-H1235. PubMed  Europe PubMed DOI
  404. [YEAR:3-6-2003]Higashi,S. and Miyazaki,K.
    Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A
    Biochemistry (3-6-2003) 42, 6514-6526. PubMed  Europe PubMed DOI
  405. [YEAR:18-4-2003]Higashi,S. and Miyazaki,K.
    Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity
    J Biol Chem (18-4-2003) 278, 14020-14028. PubMed  Europe PubMed DOI
  406. [YEAR:23-10-2003]Lafleur,M.A., Tester,A.M. and Thompson,E.W.
    Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism
    FEBS Lett (23-10-2003) 553, 457-463. PubMed  Europe PubMed DOI
  407. Lauer-Fields,J.L., Sritharan,T., Stack,M.S., Nagase,H. and Fields,G.B.
    Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9
    J Biol Chem (2003) 278, 18140-18145. PubMed  Europe PubMed DOI
  408. [YEAR:15-7-2003]Miao,X., Yu,C., Tan,W., Xiong,P., Liang,G., Lu,W. and Lin,D.
    A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma
    Cancer Res (15-7-2003) 63, 3987-3990. PubMed  Europe PubMed  M
  409. Ohno-Matsui,K., Uetama,T., Yoshida,T., Hayano,M., Itoh,T., Morita,I. and Mochizuki,M.
    Reduced retinal angiogenesis in MMP-2-deficient mice
    Invest Ophthalmol Vis Sci (2003) 44, 5370-5375. PubMed  Europe PubMed DOI  K
  410. [YEAR:18-7-2003]Rosenblum,G., Meroueh,S.O., Kleifeld,O., Brown,S., Singson,S.P., Fridman,R., Mobashery,S. and Sagi,I.
    Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2)
    J Biol Chem (18-7-2003) 278, 27009-27015. PubMed  Europe PubMed DOI
  411. [YEAR:4-4-2003]Trexler,M., Briknarova,K., Gehrmann,M., Llinas,M. and Patthy,L.
    Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2)
    J Biol Chem (4-4-2003) 278, 12241-12246. PubMed  Europe PubMed DOI
  412. Vasku,A., Goldbergova,M., Holla,L.I., Spinarova,L., Spinar,J., Vitovec,J. and Vacha,J.
    Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure
    Clin Chem Lab Med (2003) 41, 1299-1303. PubMed  Europe PubMed DOI  M
  413. Zhang,K., McQuibban,G.A., Silva,C., Butler,G.S., Johnston,J.B., Holden,J., Clark-Lewis,I., Overall,C.M. and Power,C.
    HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration
    Nat Neurosci (2003) 6, 1064-1071. PubMed  Europe PubMed DOI
    414. 2002
  414. [YEAR:3-5-2002]Bannikov,G.A., Karelina,T.V., Collier,I.E., Marmer,B.L. and Goldberg,G.I.
    Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide
    J Biol Chem (3-5-2002) 277, 16022-16027. PubMed  Europe PubMed DOI
  415. [YEAR:8-2-2002]Chen,E.I., Kridel,S.J., Howard,E.W., Li,W., Godzik,A. and Smith,J.W.
    A unique substrate recognition profile for matrix metalloproteinase-2
    J Biol Chem (8-2-2002) 277, 4485-4491. PubMed  Europe PubMed DOI
  416. [YEAR:29-7-2002]Feng,Y., Likos,J.J., Zhu,L., Woodward,H., Munie,G., McDonald,J.J., Stevens,A.M., Howard,C.P., De Crescenzo,G.A., Welsch,D., Shieh,H.S. and Stallings,W.C.
    Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor
    Biochim Biophys Acta (29-7-2002) 1598, 10-23. PubMed  Europe PubMed  S  I
  417. Gehrmann,M., Briknarova,K., Banyai,L., Patthy,L. and Llinas,M.
    The col-1 module of human matrix metalloproteinase-2 (MMP-2): Structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains
    Biol Chem (2002) 383, 137-148. PubMed  Europe PubMed DOI
  418. Longo,G.M., Xiong,W., Greiner,T.C., Zhao,Y., Fiotti,N. and Baxter,B.T.
    Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
    J Clin Invest (2002) 110, 625-632. PubMed  Europe PubMed DOI  PMC  EPMC
  419. [YEAR:28-5-2002]Morgunova,E., Tuuttila,A., Bergmann,U. and Tryggvason,K.
    Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2
    Proc Natl Acad Sci U S A (28-5-2002) 99, 7414-7419. PubMed  Europe PubMed DOI  PMC  EPMC  S
    420. 2001

  420. Sulfone reverse hydroxamates as matrix metalloproteinase inhibitors
    Expert Opin Ther Pat (2001) 11, 133-143. DOI  V  I
  421. [YEAR:2-3-2001]Atkinson,S.J., Patterson,M.L., Butler,M.J. and Murphy,G.
    Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model
    FEBS Lett (2-3-2001) 491, 222-226. PubMed  Europe PubMed DOI
  422. [YEAR:8-6-2001]Berton,A., Rigot,V., Huet,E., Decarme,M., Eeckhout,Y., Patthy,L., Godeau,G., Hornebeck,W., Bellon,G. and Emonard,H.
    Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids
    J Biol Chem (8-6-2001) 276, 20458-20465. PubMed  Europe PubMed DOI  I
  423. [YEAR:20-7-2001]Briknarova,K., Gehrmann,M., Banyai,L., Tordai,H., Patthy,L. and Llinas,M.
    Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct
    J Biol Chem (20-7-2001) 276, 27613-27621. PubMed  Europe PubMed DOI
  424. Chen,J.M., Fortunato,M., Stevens,R.A.E. and Barrett,A.J.
    Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase
    Biol Chem (2001) 382, 777-783. PubMed  Europe PubMed DOI
  425. [YEAR:15-2-2001]Deryugina,E.I., Ratnikov,B., Monosov,E., Postnova,T.I., DiScipio,R., Smith,J.W. and Strongin,A.Y.
    MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells
    Exp Cell Res (15-2-2001) 263, 209-223. PubMed  Europe PubMed DOI
  426. Fray,M.J., Burslem,M.F. and Dickinson,R.P.
    Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality
    Bioorg Med Chem Lett (2001) 11, 567-570. PubMed  Europe PubMed DOI  I
  427. Han,Y.P., Tuan,T.L., Wu,H., Hughes,M. and Garner,W.L.
    TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP
    J Cell Sci (2001) 114, 131-139. PubMed  Europe PubMed  PMC  EPMC
  428. Ihara,M., Tomimoto,H., Kinoshita,M., Oh,J., Noda,M., Wakita,H., Akiguchi,I. and Shibasaki,H.
    Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter
    J Cereb Blood Flow Metab (2001) 21, 828-834. PubMed  Europe PubMed DOI
  429. [YEAR:3-9-2001]Itoh,Y., Takamura,A., Ito,N., Maru,Y., Sato,H., Suenaga,N., Aoki,T. and Seiki,M.
    Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion
    EMBO J (3-9-2001) 20, 4782-4793. PubMed  Europe PubMed DOI  PMC  EPMC
  430. Jackson,C., Nguyen,M., Arkell,J. and Sambrook,P.
    Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis - Targetting gelatinase A activation
    Inflamm Res (2001) 50, 183-186. PubMed  Europe PubMed DOI
  431. [YEAR:18-5-2001]Kleifeld,O., Kotra,L.P., Gervasi,D.C., Brown,S., Bernardo,M.M., Fridman,R., Mobashery,S. and Sagi,I.
    X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. Comparison with the latent and active forms of the enzyme
    J Biol Chem (18-5-2001) 276, 17125-17131. PubMed  Europe PubMed DOI  S  I
  432. Kraft,P.J., Haynes-Johnson,D.E., Patel,L., Lenhart,J.A., Zivin,R.A. and Palmer,S.S.
    Fluorescence polarization assay and SDS-PAGE confirms matrilysin degrades fibronectin and collagen IV whereas gelatinase a degrades collagen IV but not fibronectin
    Connect Tissue Res (2001) 42, 149-163. PubMed  Europe PubMed
  433. [YEAR:1-7-2001]Lafleur,M.A., Hollenberg,M.D., Atkinson,S.J., Knauper,V., Murphy,G. and Edwards,D.R.
    Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species
    Biochem J (1-7-2001) 357, 107-115. PubMed  Europe PubMed DOI  PMC  EPMC
  434. Lijnen,H.R., Maquoi,E., Holvoet,P., Mertens,A., Lupu,F., Morange,P., Alessi,M.C. and Juhan-Vague,I.
    Adipose tissue expression of gelatinases in mouse models of obesity
    Thromb Haemost (2001) 85, 1111-1116. PubMed  Europe PubMed
  435. Martignetti,J.A., Aqeel,A.A., Sewairi,W.A., Boumah,C.E., Kambouris,M., Mayouf,S.A., Sheth,K.V., Eid,W.A., Dowling,O., Harris,J., Glucksman,M.J., Bahabri,S., Meyer,B.F. and Desnick,R.J.
    Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome
    Nat Genet (2001) 28, 261-265. PubMed  Europe PubMed DOI
  436. [YEAR:15-5-2001]Medina,O.P., Soderlund,T., Laakkonen,L.J., Tuominen,E.K., Koivunen,E. and Kinnunen,P.K.
    Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro
    Cancer Res (15-5-2001) 61, 3978-3985. PubMed  Europe PubMed  I
  437. [YEAR:14-12-2001]Morrison,C.J., Butler,G.S., Bigg,H.F., Roberts,C.R., Soloway,P.D. and Overall,C.M.
    Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway
    J Biol Chem (14-12-2001) 276, 47402-47410. PubMed  Europe PubMed DOI
  438. Natchus,M.G., Bookland,R.G., Laufersweiler,M.J., Pikul,S., Almstead,N.G., De,B., Janusz,M.J., Hsieh,L.C., Gu,F., Pokross,M.E., Patel,V.S., Garver,S.M., Peng,S.X., Branch,T.M., King,S.L., Baker,T.R., Foltz,D.J. and Mieling,G.E.
    Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines
    J Med Chem (2001) 44, 1060-1071. PubMed  Europe PubMed DOI  I
  439. [YEAR:17-8-2001]Patterson,M.L., Atkinson,S.J., Knauper,V. and Murphy,G.
    Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain
    FEBS Lett (17-8-2001) 503, 158-162. PubMed  Europe PubMed DOI
  440. [YEAR:6-4-2001]Pekovich,S.R., Bock,P.E. and Hoover,R.L.
    Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A
    FEBS Lett (6-4-2001) 494, 129-132. PubMed  Europe PubMed DOI
  441. [YEAR:9-3-2001]Price,S.J., Greaves,D.R. and Watkins,H.
    Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation
    J Biol Chem (9-3-2001) 276, 7549-7558. PubMed  Europe PubMed DOI  M
  442. [YEAR:1-1-2001]Puyraimond,A., Fridman,R., Lemesle,M., Arbeille,B. and Menashi,S.
    MMP-2 colocalizes with caveolae on the surface of endothelial cells
    Exp Cell Res (1-1-2001) 262, 28-36. PubMed  Europe PubMed DOI
  443. Ruangpanit,N., Chan,D., Holmbeck,K., Birkedal-Hansen,H., Polarek,J., Yang,C., Bateman,J.F. and Thompson,E.W.
    Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form
    Matrix Biol (2001) 20, 193-203. PubMed  Europe PubMed DOI
  444. Shamamian,P., Schwartz,J.D., Pocock,B.J., Monea,S., Whiting,D., Marcus,S.G. and Mignatti,P.
    Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: A role for inflammatory cells in tumor invasion and angiogenesis
    J Cell Physiol (2001) 189, 197-206. PubMed  Europe PubMed DOI
  445. [YEAR:16-3-2001]Yang,Z., Strickland,D.K. and Bornstein,P.
    Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2
    J Biol Chem (16-3-2001) 276, 8403-8408. PubMed  Europe PubMed DOI
    446. 2000
  446. [YEAR:25-8-2000]Caterina,J.J., Yamada,S., Caterina,N.C., Longenecker,G., Holmback,K., Shi,J., Yermovsky,A.E., Engler,J.A. and Birkedal-Hansen,H.
    Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (Timp-2) gene alters proMMP-2 activation
    J Biol Chem (25-8-2000) 275, 26416-26422. PubMed  Europe PubMed DOI
  447. Fasciglione,G.F., Marini,S., D'Alessio,S., Politi,V. and Coletta,M.
    pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B
    Biophys J (2000) 79, 2138-2149. PubMed  Europe PubMed DOI  PMC  EPMC
  448. [YEAR:20-9-2000]Gingras,D., Page,M., Annabi,B. and Beliveau,R.
    Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism
    Biochim Biophys Acta (20-9-2000) 1497, 341-350. PubMed  Europe PubMed DOI
  449. [YEAR:18-8-2000]McQuibban,G.A., Gong,J.H., Tam,E.M., McCulloch,C.A., Clark-Lewis,I. and Overall,C.M.
    Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
    Science (18-8-2000) 289, 1202-1206. PubMed  Europe PubMed DOI
  450. [YEAR:15-12-2000]Overall,C.M., Tam,E., McQuibban,G.A., Morrison,C., Wallon,U.M., Bigg,H.F., King,A.E. and Roberts,C.R.
    Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation
    J Biol Chem (15-12-2000) 275, 39497-39506. PubMed  Europe PubMed DOI
    451. 1999
  451. [YEAR:15-10-1999]Briknarova,K., Grishaev,A., Banyai,L., Tordai,H., Patthy,L. and Llinas,M.
    The second type II module from human matrix metalloproteinase 2: structure, function and dynamics
    Structure (15-10-1999) 7, 1235-1245. PubMed  Europe PubMed DOI
  452. [YEAR:16-4-1999]Butler,G.S., Apte,S.S., Willenbrock,F. and Murphy,G.
    Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions
    J Biol Chem (16-4-1999) 274, 10846-10851. PubMed  Europe PubMed DOI
  453. [YEAR:12-11-1999]Fernandez-Patron,C., Radomski,M.W. and Davidge,S.T.
    Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor
    Circ Res (12-11-1999) 85, 906-911. PubMed  Europe PubMed
  454. [YEAR:25-8-1999]Makela,M., Larjava,H., Pirila,E., Maisi,P., Salo,T., Sorsa,T. and Uitto,V.J.
    Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes
    Exp Cell Res (25-8-1999) 251, 67-78. PubMed  Europe PubMed DOI  I
  455. [YEAR:4-6-1999]Morgunova,E., Tuuttila,A., Bergmann,U., Isupov,M., Lindqvist,Y., Schneider,G. and Tryggvason,K.
    Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
    Science (4-6-1999) 284, 1667-1670. PubMed  Europe PubMed DOI  S
  456. Nguyen,M., Arkell,J. and Jackson,C.J.
    Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase
    Lab Invest (1999) 79, 467-475. PubMed  Europe PubMed
  457. [YEAR:12-2-1999]Overall,C.M., King,A.E., Sam,D.K., Ong,A.D., Lau,T.T., Wallon,U.M., DeClerck,Y.A. and Atherstone,J.
    Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV
    J Biol Chem (12-2-1999) 274, 4421-4429. PubMed  Europe PubMed DOI
  458. [YEAR:30-7-1999]Passi,A., Negrini,D., Albertini,R., Miserocchi,G. and De Luca,G.
    The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema
    FEBS Lett (30-7-1999) 456, 93-96. PubMed  Europe PubMed DOI
    459. 1998
  459. [YEAR:9-1-1998]Butler,G.S., Butler,M.J., Atkinson,S.J., Will,H., Tamura,T., Schade van Westrum,S., Crabbe,T., Clements,J., d'Ortho,M.P. and Murphy,G.
    The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
    J Biol Chem (9-1-1998) 273, 871-880. PubMed  Europe PubMed DOI
  460. [YEAR:15-7-1998]Farina,A.R., Tacconelli,A., Teti,A., Gulino,A. and Mackay,A.R.
    Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate
    Cancer Res (15-7-1998) 58, 2957-2960. PubMed  Europe PubMed
  461. [YEAR:19-6-1998]Ferry,G., Boutin,J.A., Hennig,P., Genton,A., Desmet,C., Fauchere,J.L., Atassi,G. and Tucker,G.C.
    A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects
    Eur J Pharmacol (19-6-1998) 351, 225-233. PubMed  Europe PubMed DOI  I
  462. Hayashi,K., Osada,S., Shofuda,K., Horikoshi,S., Shirato,I. and Tomino,Y.
    Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis
    J Am Soc Nephrol (1998) 9, 2262-2271. PubMed  Europe PubMed
  463. [YEAR:14-7-1998]Hutton,M., Willenbrock,F., Brocklehurst,K. and Murphy,G.
    Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: Evidence for the existence of a low-affinity intermediate
    Biochemistry (14-7-1998) 37, 10094-10098. PubMed  Europe PubMed DOI
  464. [YEAR:1-3-1998]Itoh,T., Tanioka,M., Yoshida,H., Yoshioka,T., Nishimoto,H. and Itohara,S.
    Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
    Cancer Res (1-3-1998) 58, 1048-1051. PubMed  Europe PubMed
  465. [YEAR:18-9-1998]Itoh,Y., Ito,A., Iwata,K., Tanzawa,K., Mori,Y. and Nagase,H.
    Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface
    J Biol Chem (18-9-1998) 273, 24360-24367. PubMed  Europe PubMed DOI
  466. [YEAR:26-6-1998]Kinoshita,T., Sato,H., Okada,A., Ohuchi,E., Imai,K., Okada,Y. and Seiki,M.
    TIMP-2 promotes activation of progelatinase a by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
    J Biol Chem (26-6-1998) 273, 16098-16103. PubMed  Europe PubMed DOI
  467. [YEAR:1-9-1998]Lehti,K., Lohi,J., Valtanen,H. and Keski-Oja,J.
    Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
    Biochem J (1-9-1998) 334, 345-353. PubMed  Europe PubMed  PMC  EPMC
  468. Lijnen,H.R., Silence,J., Lemmens,G., Frederix,L. and Collen,D.
    Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
    Thromb Haemost (1998) 79, 1171-1176. PubMed  Europe PubMed
  469. [YEAR:13-3-1998]Maquoi,E., Noel,A., Frankenne,F., Angliker,H., Murphy,G. and Foidart,J.M.
    Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor
    FEBS Lett (13-3-1998) 424, 262-266. PubMed  Europe PubMed DOI  I
  470. Xuan,J.W., Tuck,A.B., Wilson,S.M., Chin,J.L. and Chambers,A.F.
    MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells
    Anticancer Res (1998) 18, 743-749. PubMed  Europe PubMed
    471. 1997
  471. Bigg,H.F., Shi,Y.E., Liu,Y.E., Steffensen,B. and Overall,C.M.
    Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2
    J Biol Chem (1997) 272, 15496-15500. PubMed  Europe PubMed DOI
  472. Burns,E.H., Jr., Marciel,A.M. and Musser,J.M.
    Structure-function and pathogenesis studies of Streptococcus pyogenes extracellular cysteine protease
    Adv Exp Med Biol (1997) 418, 589-592. PubMed  Europe PubMed
  473. Deryugina,E.I., Luo,G.X., Reisfeld,R.A., Bourdon,M.A. and Strongin,A.
    Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2
    Anticancer Res (1997) 17, 3201-3210. PubMed  Europe PubMed
  474. Kolkenbrock,H., Hecker-Kia,A., Orgel,D., Ulbrich,N. and Will,H.
    Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase
    Biol Chem (1997) 378, 71-76. PubMed  Europe PubMed
  475. Okada,A., Tomasetto,C., Lutz,Y., Bellocq,J.P., Rio,M.C. and Basset,P.
    Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A
    J Cell Biol (1997) 137, 67-77. PubMed  Europe PubMed DOI  PMC  EPMC
  476. Quesada,A.R., Barbacid,M.M., Mira,E., Fernandez-Resa,P., Marquez,G. and Aracil,M.
    Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases
    Clin Exp Metastasis (1997) 15, 26-32. PubMed  Europe PubMed DOI  A
  477. Ueno,H., Nakamura,H., Inoue,M., Imai,K., Noguchi,M., Sato,H., Seiki,M. and Okada,Y.
    Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas
    Cancer Res (1997) 57, 2055-2060. PubMed  Europe PubMed
    478. 1996
  478. [YEAR:31-5-1996]Brooks,P.C., Stromblad,S., Sanders,L.C., von Schalscha,T.L., Aimes,R.T., Stetler-Stevenson,W.G., Quigley,J.P. and Cheresh,D.A.
    Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
    Cell (31-5-1996) 85, 683-693. PubMed  Europe PubMed DOI
  479. Fishman,D.A., Bafetti,L.M. and Stack,M.S.
    Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells
    Invasion Metastasis (1996) 16, 150-159. PubMed  Europe PubMed
  480. Gohlke,U., Gomis-Ruth,F.X., Crabbe,T., Murphy,G., Docherty,A.J. and Bode,W.
    The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function
    FEBS Lett (1996) 378, 126-130. PubMed  Europe PubMed DOI
    481. 1995
  481. Atkinson,S.J., Crabbe,T., Cowell,S., Ward,R.V., Butler,M.J., Sato,H., Seiki,M., Reynolds,J.J. and Murphy,G.
    Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes
    J Biol Chem (1995) 270, 30479-30485. PubMed  Europe PubMed DOI
  482. Chander,S.K., Antoniw,P., Beeley,N.R., Boyce,B., Crabbe,T., Docherty,A.J., Leonard,J., Mason,B., Millar,K. and Millican,A.T.
    An in vivo model for screening peptidomimetic inhibitors of gelatinase A
    J Pharm Sci (1995) 84, 404-409. PubMed  Europe PubMed DOI  I
  483. [YEAR:15-6-1995]Fridman,R., Toth,M., Pena,D. and Mobashery,S.
    Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
    Cancer Res (15-6-1995) 55, 2548-2555. PubMed  Europe PubMed
  484. [YEAR:1-6-1995]Itoh,Y., Binner,S. and Nagase,H.
    Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate
    Biochem J (1-6-1995) 308, 645-651. PubMed  Europe PubMed  PMC  EPMC
  485. Libson,A.M., Gittis,A.G., Collier,I.E., Marmer,B.L., Goldberg,G.I. and Lattman,E.E.
    Crystal structure of the haemopexin-like C-terminal domain of gelatinase A
    Nat Struct Biol (1995) 2, 938-942. PubMed  Europe PubMed  S
  486. Murphy,G. and Crabbe,T.
    Gelatinases A and B
    Methods Enzymol (1995) 248, 470-484. PubMed  Europe PubMed DOI  V
    487. 1994
  487. Aimes,R.T., French,D.L. and Quigley,J.P.
    Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: Expression of the gelatinase increases upon malignant transformation
    Biochem J (1994) 300, 729-736. PubMed  Europe PubMed  PMC  EPMC
  488. Brown,F.K., Brown,P.J., Bickett,D.M., Chambers,C.L., Davies,H.G., Deaton,D.N., Drewry,D., Foley,M., McElroy,A.B., Gregson,M., McGeehan,G.M., Myers,P.L., Norton,D., Salovich,J.M., Schoenen,F.J. and Ward,P.
    Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues
    J Med Chem (1994) 37, 674-688. PubMed  Europe PubMed  I
  489. Crabbe,T., Zucker,S., Cockett,M.I., Willenbrock,F., Tickle,S., O'Connell,J.P., Scothern,J.M., Murphy,G. and Docherty,A.J.
    Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1
    Biochemistry (1994) 33, 6684-6690. PubMed  Europe PubMed DOI
  490. [YEAR:23-5-1994]Crabbe,T., Smith,B., O'Connell,J. and Docherty,A.
    Human progelatinase A can be activated by matrilysin
    FEBS Lett (23-5-1994) 345, 14-16. PubMed  Europe PubMed DOI
  491. Crabbe,T., O'Connell,J.P., Smith,B.J. and Docherty,A.J.
    Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A
    Biochemistry (1994) 33, 14419-14425. PubMed  Europe PubMed
  492. [YEAR:14-10-1994]Fowlkes,J.L., Enghild,J.J., Suzuki,K. and Nagase,H.
    Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
    J Biol Chem (14-10-1994) 269, 25742-25746. PubMed  Europe PubMed  P
  493. [YEAR:1-11-1994]Monsky,W.L., Lin,C.Y., Aoyama,A., Kelly,T., Akiyama,S.K., Mueller,S.C. and Chen,W.T.
    A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells
    Cancer Res (1-11-1994) 54, 5702-5710. PubMed  Europe PubMed
  494. Nguyen,Q., Willenbrock,F., Cockett,M.I., O'Shea,M., Docherty,A.J. and Murphy,G.
    Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A
    Biochemistry (1994) 33, 2089-2095. PubMed  Europe PubMed
  495. [YEAR:29-11-1994]Ochieng,J., Fridman,R., Nangia-Makker,P., Kleiner,D.E., Liotta,L.A., Stetler-Stevenson,W.G. and Raz,A.
    Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9
    Biochemistry (29-11-1994) 33, 14109-14114. PubMed  Europe PubMed DOI
  496. Roher,A.E., Kasunic,T.C., Woods,A.S., Cotter,R.J., Ball,M.J. and Fridman,R.
    Proteolysis of Abeta peptide from Alzheimer disease brain by gelatinase A
    Biochem Biophys Res Commun (1994) 205, 1755-1761. PubMed  Europe PubMed DOI
  497. Sato,H., Takino,T., Okada,Y., Cao,J., Shinagawa,A., Yamamoto,E. and Seiki,M.
    A matrix metalloproteinase expressed on the surface of invasive tumour cells
    Nature (1994) 370, 61-65. PubMed  Europe PubMed DOI
    498. 1993
  498. Brown,P.D., Bloxidge,R.E., Stuart,N.S., Gatter,K.C. and Carmichael,J.
    Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma
    J Natl Cancer Inst (1993) 85, 574-578. PubMed  Europe PubMed
  499. Brown,P.D., Bloxidge,R.E., Anderson,E. and Howell,A.
    Expression of activated gelatinase in human invasive breast carcinoma
    Clin Exp Metastasis (1993) 11, 183-189. PubMed  Europe PubMed
  500. Crabbe,T., Ioannou,C. and Docherty,A.J.
    Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain
    Eur J Biochem (1993) 218, 431-438. PubMed  Europe PubMed DOI
  501. Fridman,R., Bird,R.E., Hoyhtya,M., Oelkuct,M., Komarek,D., Liang,C.M., Berman,M.L., Liotta,L.A., Stetler-Stevenson,W.G. and Fuerst,T.R.
    Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme
    Biochem J (1993) 289, 411-416. PubMed  Europe PubMed  PMC  EPMC  E
  502. Strongin,A.Y., Marmer,B.L., Grant,G.A. and Goldberg,G.I.
    Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP- 2
    J Biol Chem (1993) 268, 14033-14039. PubMed  Europe PubMed
  503. [YEAR:27-4-1993]Willenbrock,F., Crabbe,T., Slocombe,P.M., Sutton,C.W., Docherty,A.J., Cockett,M.I., O'Shea,M., Brocklehurst,K., Phillips,I.R. and Murphy,G.
    The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A
    Biochemistry (27-4-1993) 32, 4330-4337. PubMed  Europe PubMed
    504. 1992
  504. Kleiner,D.E., Jr., Unsworth,E.J., Krutzsch,H.C. and Stetler-Stevenson,W.G.
    Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases- 2
    Biochemistry (1992) 31, 1665-1672. PubMed  Europe PubMed
  505. Murphy,G., Willenbrock,F., Ward,R.V., Cockett,M.I., Eaton,D. and Docherty,A.J.
    The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
    Biochem J (1992) 283, 637-641. PubMed  Europe PubMed  PMC  EPMC
  506. Reponen,P., Sahlberg,C., Huhtala,P., Hurskainen,T., Thesleff,I. and Tryggvason,K.
    Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development
    J Biol Chem (1992) 267, 7856-7862. PubMed  Europe PubMed
    507. 1991
  507. Chen,J.M., Aimes,R.T., Ward,G.R., Youngleib,G.L. and Quigley,J.P.
    Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts
    J Biol Chem (1991) 266, 5113-5121. PubMed  Europe PubMed
  508. Howard,E.W. and Banda,M.J.
    Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site
    J Biol Chem (1991) 266, 17972-17977. PubMed  Europe PubMed
  509. Kolkenbrock,H., Orgel,D., Hecker-Kia,A., Noack,W. and Ulbrich,N.
    The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor
    Eur J Biochem (1991) 198, 775-781. PubMed  Europe PubMed
  510. Mast,A.E., Enghild,J.J., Nagase,H., Suzuki,K., Pizzo,S.V. and Salvesen,G.
    Kinetics and physiologic relevance of the inactivation of alpha1- proteinase inhibitor, alpha1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin)
    J Biol Chem (1991) 266, 15810-15816. PubMed  Europe PubMed
  511. Ward,R.V., Hembry,R.M., Reynolds,J.J. and Murphy,G.
    The purification of tissue inhibitor of metalloproteinases- 2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases- 2 and tissue inhibitor of metalloproteinases-1
    Biochem J (1991) 278, 179-187. PubMed  Europe PubMed  PMC  EPMC
  512. Woessner,J.F., Jr.
    Matrix metalloproteinases and their inhibitors in connective tissue remodeling
    FASEB J (1991) 5, 2145-2154. PubMed  Europe PubMed
    513. 1990
  513. Okada,Y., Morodomi,T., Enghild,J.J., Suzuki,K., Yasui,A., Nakanishi,I., Salvesen,G. and Nagase,H.
    Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
    Eur J Biochem (1990) 194, 721-730. PubMed  Europe PubMed
    514. 1988
  514. Collier,I.E., Wilhelm,S.M., Eisen,A.Z., Marmer,B.L., Grant,G.A., Seltzer,J.L., Kronberger,A., He,C.S., Bauer,E.A. and Goldberg,G.I.
    H-ras oncogene-transformed human bronchial epithelial cells (TBE- 1) secrete a single metalloprotease capable of degrading basement membrane collagen
    J Biol Chem (1988) 263, 6579-6587. PubMed  Europe PubMed
    515. 1985
  515. Murphy,G., McAlpine,C.G., Poll,C.T. and Reynolds,J.J.
    Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen
    Biochim Biophys Acta (1985) 831, 49-58. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use